This is a table of named entities, their types, and their frequencies from sentences in your study carrel. Use it to search & browse the list to learn more about your study carrel. Please keep in mind that named-entity extraction is not as accurate as more generic parts-of-speech extraction. Unusual results will appear here.
| entity | type | frequency |
|---|---|---|
| angiotensin | CHEMICAL | 708 |
| covid | ORG | 428 |
| ang ii | PERSON | 412 |
| sars | DISEASE | 381 |
| angiotensin ii | ORG | 305 |
| hypertension | DISEASE | 276 |
| mice | TAXON | 252 |
| ace | ORG | 215 |
| angiotensin | CHEMICAL | 208 |
| angii | GPE | 200 |
| human | TAXON | 196 |
| sars cov 2 | ORG | 191 |
| covid 19 | ORG | 178 |
| virus | TAXON | 175 |
| coronavirus | TAXON | 173 |
| viral | TAXON | 172 |
| inflammation | DISEASE | 172 |
| rats | TAXON | 165 |
| cov | ORG | 155 |
| infection | DISEASE | 155 |
| fibrosis | DISEASE | 149 |
| rat | TAXON | 145 |
| sars cov | ORG | 127 |
| angiotensin ii | CHEMICAL | 116 |
| acei | ORG | 116 |
| diabetes | DISEASE | 109 |
| hypertensive | DISEASE | 107 |
| ang | PERSON | 106 |
| aceis | CHEMICAL | 97 |
| glucose | CHEMICAL | 95 |
| arbs | CHEMICAL | 93 |
| arb | ORG | 92 |
| nep | TAXON | 91 |
| mas | ORG | 91 |
| animal | TAXON | 79 |
| captopril | CHEMICAL | 78 |
| ace inhibitors | CHEMICAL | 77 |
| prorenin | CHEMICAL | 75 |
| diabetic | DISEASE | 71 |
| ras | LOC | 69 |
| china | GPE | 69 |
| sodium | CHEMICAL | 68 |
| cancer | DISEASE | 68 |
| bradykinin | CHEMICAL | 67 |
| death | DISEASE | 65 |
| cardiovascular disease | DISEASE | 65 |
| k | CHEMICAL | 65 |
| tumor | DISEASE | 61 |
| angiotensin i | CHEMICAL | 61 |
| potassium | CHEMICAL | 58 |
| losartan | CHEMICAL | 57 |
| lung injury | DISEASE | 56 |
| acei arb | ORG | 56 |
| wuhan | GPE | 55 |
| mouse | TAXON | 53 |
| amino acid | CHEMICAL | 53 |
| aldosterone | CHEMICAL | 52 |
| ang 1 7 | PERSON | 52 |
| individuals | TAXON | 52 |
| heart failure | DISEASE | 51 |
| pneumonia | DISEASE | 50 |
| humans | TAXON | 49 |
| oxygen | CHEMICAL | 46 |
| hypokalaemia | DISEASE | 45 |
| diabetic nephropathy | DISEASE | 45 |
| ards | GPE | 45 |
| ace 2 | ORG | 45 |
| cvd | ORG | 44 |
| coronavirus disease | DISEASE | 44 |
| coronavirus | TAXON | 44 |
| tnf | ORG | 40 |
| tgf | ORG | 39 |
| dm | CHEMICAL | 39 |
| renin | PERSON | 37 |
| no | CHEMICAL | 37 |
| apelin | CHEMICAL | 36 |
| amino acids | CHEMICAL | 36 |
| nitric oxide | CHEMICAL | 36 |
| proteinuria | DISEASE | 36 |
| obesity | DISEASE | 36 |
| gbm | ORG | 35 |
| glomerulosclerosis | DISEASE | 34 |
| yeast | TAXON | 33 |
| prr | ORG | 33 |
| orx | ORG | 33 |
| agt | ORG | 33 |
| angiotensin aldosterone | CHEMICAL | 32 |
| gut microbiota | PERSON | 31 |
| diabetes mellitus | DISEASE | 31 |
| n | ORG | 31 |
| mas | ORG | 31 |
| neratinib | GPE | 30 |
| myocardial infarction | DISEASE | 30 |
| hypoxia | DISEASE | 30 |
| animals | TAXON | 30 |
| bp | ORG | 29 |
| cholesterol | CHEMICAL | 29 |
| respiratory distress syndrome | DISEASE | 28 |
| aliskiren | ORG | 28 |
| ncov | ORG | 27 |
| hypertrophy | DISEASE | 27 |
| atherosclerosis | DISEASE | 27 |
| acetate | CHEMICAL | 27 |
| vsmc | ORG | 26 |
| gtp | ORG | 26 |
| ii | ORG | 26 |
| nephropathy | DISEASE | 26 |
| tyrosine | CHEMICAL | 26 |
| vivo | GPE | 26 |
| golgi | GPE | 25 |
| dm ab | ORG | 25 |
| stroke | DISEASE | 24 |
| ang | ORG | 24 |
| ang ii | ORG | 23 |
| hypertension | DISEASE | 23 |
| estrogen | CHEMICAL | 23 |
| thrombosis | DISEASE | 22 |
| calcium | CHEMICAL | 22 |
| zinc | CHEMICAL | 21 |
| vasopressin | CHEMICAL | 21 |
| wt | ORG | 21 |
| rna | PERSON | 21 |
| ang iii | PERSON | 21 |
| nadph | CHEMICAL | 20 |
| ace inhibitor | CHEMICAL | 20 |
| ckd | ORG | 20 |
| fsgs | ORG | 20 |
| human | TAXON | 20 |
| ave | ORG | 20 |
| prorenin | ORG | 20 |
| angiotensin 1 7 | CHEMICAL | 20 |
| endothelial dysfunction | DISEASE | 20 |
| olmesartan | GPE | 20 |
| viruses | TAXON | 20 |
| albuminuria | GPE | 20 |
| cardiac hypertrophy | DISEASE | 19 |
| cancer | DISEASE | 19 |
| alzheimer s disease | DISEASE | 19 |
| kinin | CHEMICAL | 19 |
| osteoporosis | DISEASE | 19 |
| renal injury | DISEASE | 19 |
| cardiovascular diseases | DISEASE | 18 |
| map | ORG | 18 |
| egfr | ORG | 18 |
| viral infection | DISEASE | 17 |
| respiratory syndrome | DISEASE | 17 |
| acute lung injury | DISEASE | 17 |
| il | GPE | 17 |
| ibd | DISEASE | 17 |
| c21 | PERSON | 17 |
| aliskiren | ORG | 16 |
| mice | TAXON | 16 |
| amp | ORG | 16 |
| hxt9 | PERSON | 16 |
| lung cancer | DISEASE | 16 |
| vlp | ORG | 16 |
| superoxide | CHEMICAL | 16 |
| chloride | CHEMICAL | 16 |
| cardiac dysfunction | DISEASE | 15 |
| bradykinin | GPE | 15 |
| losartan | GPE | 15 |
| nad | ORG | 15 |
| candesartan | CHEMICAL | 15 |
| stz | ORG | 15 |
| colitis | DISEASE | 15 |
| dysbiosis | DISEASE | 15 |
| murine | TAXON | 15 |
| pulmonary hypertension | DISEASE | 15 |
| virus infection | DISEASE | 15 |
| grp | ORG | 14 |
| ad | DISEASE | 14 |
| ace2 | PERSON | 14 |
| animal | TAXON | 14 |
| apelin | PERSON | 14 |
| coronavirus disease | DISEASE | 14 |
| diabetes | DISEASE | 14 |
| tyrosine | CHEMICAL | 14 |
| kidney disease | DISEASE | 14 |
| lung tumor | DISEASE | 14 |
| streptozotocin | CHEMICAL | 14 |
| tumor necrosis | DISEASE | 14 |
| mers | DISEASE | 14 |
| coronavirus disease | DISEASE | 13 |
| sars coronavirus | DISEASE | 13 |
| ang iv | ORG | 13 |
| co2 | ORG | 13 |
| angiotensin ii ang ii | PERSON | 13 |
| afatinib | GPE | 13 |
| cirrhosis | DISEASE | 13 |
| type 2 diabetes | DISEASE | 13 |
| g | ORG | 12 |
| ros | PERSON | 12 |
| nrf2 | ORG | 12 |
| xci | ORG | 12 |
| e1 qi | CHEMICAL | 12 |
| acsdkp | ORG | 12 |
| ampk | ORG | 12 |
| sky197 | PERSON | 12 |
| infections | DISEASE | 12 |
| bacteria | TAXON | 12 |
| vitamin d | CHEMICAL | 12 |
| sorafenib | PERSON | 12 |
| thrombotic | DISEASE | 12 |
| tissue injury | DISEASE | 12 |
| viral infections | DISEASE | 12 |
| camp | CHEMICAL | 12 |
| endothelin | GPE | 11 |
| ace ang ii | CHEMICAL | 11 |
| bk | ORG | 11 |
| chronic | ORG | 11 |
| doca | ORG | 11 |
| enalapril | GPE | 11 |
| hf | ORG | 11 |
| cancers | DISEASE | 11 |
| raf | PERSON | 11 |
| heparin | CHEMICAL | 11 |
| metastasis | DISEASE | 11 |
| neutrophil | GPE | 11 |
| rabbit | TAXON | 11 |
| renal disease | DISEASE | 11 |
| smoking | CHEMICAL | 11 |
| statins | CHEMICAL | 11 |
| telmisartan | CHEMICAL | 11 |
| liver disease | DISEASE | 11 |
| bacterial | TAXON | 10 |
| acute respiratory syndrome | DISEASE | 10 |
| vitamin d | PERSON | 10 |
| viral | TAXON | 10 |
| ttkg | ORG | 10 |
| jnk | ORG | 10 |
| rbd | ORG | 10 |
| nash | ORG | 10 |
| loss | PERSON | 10 |
| atr | CHEMICAL | 10 |
| angioedema | DISEASE | 10 |
| mitochondrial dysfunction | DISEASE | 10 |
| chloroquine | CHEMICAL | 10 |
| threonine | CHEMICAL | 10 |
| fatty acids | CHEMICAL | 10 |
| tryptophan | GPE | 10 |
| tibia | GPE | 10 |
| vascular smooth muscle | DISEASE | 10 |
| testosterone | CHEMICAL | 10 |
| microbiome | TAXON | 10 |
| kidney injury | DISEASE | 10 |
| hyperglycemia | DISEASE | 10 |
| emt | ORG | 9 |
| ncc | ORG | 9 |
| masr | GPE | 9 |
| mers cov | ORG | 9 |
| italy | GPE | 9 |
| fibrosis | DISEASE | 9 |
| europe | LOC | 9 |
| estrogen | ORG | 9 |
| ca | CHEMICAL | 9 |
| ecm | ORG | 9 |
| ec | ORG | 9 |
| e1 | CHEMICAL | 9 |
| plasma | PERSON | 9 |
| caax | ORG | 9 |
| akita | GPE | 9 |
| acei | CHEMICAL | 9 |
| aaa | ORG | 9 |
| peep | ORG | 9 |
| mhc | ORG | 9 |
| sars cov infection | DISEASE | 9 |
| human coronavirus | TAXON | 9 |
| tumor | DISEASE | 9 |
| the united states | GPE | 9 |
| sepsis | DISEASE | 9 |
| sarcopenia | GPE | 9 |
| rodent | TAXON | 9 |
| organ damage | DISEASE | 9 |
| lipopolysaccharide | CHEMICAL | 9 |
| inositol | CHEMICAL | 9 |
| perindopril | CHEMICAL | 9 |
| hepatitis c | DISEASE | 9 |
| butyrate | CHEMICAL | 9 |
| enalapril | CHEMICAL | 9 |
| bias | CHEMICAL | 9 |
| bleomycin | CHEMICAL | 9 |
| uk | GPE | 9 |
| cgmp | CHEMICAL | 9 |
| diseases | DISEASE | 9 |
| erk | ORG | 8 |
| tlr | PERSON | 8 |
| pd | ORG | 8 |
| na | CHEMICAL | 8 |
| middle east | LOC | 8 |
| mek | ORG | 8 |
| li | CHEMICAL | 8 |
| hrp | ORG | 8 |
| gpcr | ORG | 8 |
| acute lung failure | DISEASE | 8 |
| dd | CHEMICAL | 8 |
| crohn s disease | DISEASE | 8 |
| cardiovascular | GPE | 8 |
| captopril | CHEMICAL | 8 |
| angiotensinogen | ORG | 8 |
| angiotensin aldosterone | CHEMICAL | 8 |
| atp | ORG | 8 |
| ap | ORG | 8 |
| acute kidney injury | DISEASE | 8 |
| malaria | TAXON | 8 |
| angiotensin converting | ORG | 8 |
| mammalian | TAXON | 8 |
| cardiac injury | DISEASE | 8 |
| rodents | TAXON | 8 |
| respiratory syndrome coronavirus 2 sars | DISEASE | 8 |
| respiratory syndrome coronavirus | DISEASE | 8 |
| overload | CHEMICAL | 8 |
| nicotine | CHEMICAL | 8 |
| natriuresis | DISEASE | 8 |
| myocarditis | DISEASE | 8 |
| nucleotide | CHEMICAL | 8 |
| vitro | GPE | 8 |
| injuries | DISEASE | 8 |
| hypoxemia | DISEASE | 8 |
| human podocytes | TAXON | 8 |
| dyspnea | DISEASE | 8 |
| diabetic complications | DISEASE | 8 |
| cardiovascular | GPE | 8 |
| lisinopril | CHEMICAL | 8 |
| sma | ORG | 7 |
| neratinib | GPE | 7 |
| nicotine | ORG | 7 |
| scfas | CHEMICAL | 7 |
| collectrin | CHEMICAL | 7 |
| virus | PERSON | 7 |
| yeast | TAXON | 7 |
| cis golgi | PERSON | 7 |
| hvpg | ORG | 7 |
| mek1 | CHEMICAL | 7 |
| ages | CHEMICAL | 7 |
| hpv | ORG | 7 |
| hcq | ORG | 7 |
| egf | ORG | 7 |
| drp1 | ORG | 7 |
| crohn s | PERSON | 7 |
| covs | TAXON | 7 |
| c5b 9 | CHEMICAL | 7 |
| ang 1 | PERSON | 7 |
| at2r | PERSON | 7 |
| coronavirus infection | DISEASE | 7 |
| coronavirus sars cov | DISEASE | 7 |
| pao | ORG | 7 |
| coronavirus pneumonia | DISEASE | 7 |
| hypokalemia | DISEASE | 7 |
| creatinine | CHEMICAL | 7 |
| viral rna | TAXON | 7 |
| tumors | DISEASE | 7 |
| respiratory diseases | DISEASE | 7 |
| palmitic acid | CHEMICAL | 7 |
| lysine | CHEMICAL | 7 |
| lung disease | DISEASE | 7 |
| lung damage | DISEASE | 7 |
| luminal | CHEMICAL | 7 |
| ischemia | DISEASE | 7 |
| ramipril | CHEMICAL | 7 |
| hypertensive nephrosclerosis | DISEASE | 7 |
| hyperaldosteronism | DISEASE | 7 |
| glycation | DISEASE | 7 |
| fever | DISEASE | 7 |
| fatty acid | CHEMICAL | 7 |
| diabetes infected | DISEASE | 7 |
| depression | DISEASE | 7 |
| hyperkalaemia | DISEASE | 7 |
| deaths | DISEASE | 7 |
| ren | ORG | 6 |
| nos | ORG | 6 |
| obesity | DISEASE | 6 |
| pcr | ORG | 6 |
| pdr1 | ORG | 6 |
| prevalence | ORG | 6 |
| ras blockade | DISEASE | 6 |
| sham | PERSON | 6 |
| roles | PERSON | 6 |
| sa | ORG | 6 |
| saccharomyces cerevisiae | TAXON | 6 |
| smoking | CHEMICAL | 6 |
| sprague dawley | PERSON | 6 |
| lipid | GPE | 6 |
| t2dm | PERSON | 6 |
| nih | ORG | 6 |
| aldosterone | CHEMICAL | 6 |
| individuals | TAXON | 6 |
| beclin1 | PERSON | 6 |
| xnt | ORG | 6 |
| 61l saax | PERSON | 6 |
| abo | ORG | 6 |
| anp | ORG | 6 |
| at4 | ORG | 6 |
| akt | PERSON | 6 |
| ci | ORG | 6 |
| hiv | TAXON | 6 |
| copd | ORG | 6 |
| candesartan | PERSON | 6 |
| chen | PERSON | 6 |
| fda | ORG | 6 |
| glomus | ORG | 6 |
| h1n1 | GPE | 6 |
| us | GPE | 6 |
| diabetic retinopathy | DISEASE | 6 |
| zn | PERSON | 6 |
| glomerular sclerosis | DISEASE | 6 |
| hsrpb7 | DISEASE | 6 |
| hypertension diabetes | DISEASE | 6 |
| hypotension | DISEASE | 6 |
| liver fibrosis | DISEASE | 6 |
| lung adenocarcinoma | DISEASE | 6 |
| microvascular | ORG | 6 |
| omapatrilat | CHEMICAL | 6 |
| p21ras | CHEMICAL | 6 |
| pigs | TAXON | 6 |
| pulmonary diseases | DISEASE | 6 |
| respiratory disease | DISEASE | 6 |
| ulcerative colitis | DISEASE | 6 |
| unopposed | CHEMICAL | 6 |
| acute myocardial infarction | DISEASE | 6 |
| vascular disease | DISEASE | 6 |
| host | TAXON | 6 |
| metabolic syndrome | DISEASE | 6 |
| glomerular diseases | DISEASE | 6 |
| chronic kidney disease | DISEASE | 6 |
| ethanol | CHEMICAL | 6 |
| angiotensin 1 9 | CHEMICAL | 6 |
| angiotensin peptide | CHEMICAL | 6 |
| angiotensin peptides | CHEMICAL | 6 |
| arrhythmia | DISEASE | 6 |
| bone loss | DISEASE | 6 |
| beta1 | GPE | 6 |
| cirrhotic | DISEASE | 6 |
| coronary artery disease | DISEASE | 6 |
| cough | DISEASE | 6 |
| diabetic renal injury | DISEASE | 6 |
| enalaprilat | CHEMICAL | 6 |
| acute respiratory distress syndrome | DISEASE | 6 |
| mmp | ORG | 5 |
| iv | ORG | 5 |
| il 6 | ORG | 5 |
| inflammation | DISEASE | 5 |
| irbesartan | GPE | 5 |
| ldlr | ORG | 5 |
| mapk | PERSON | 5 |
| sa βgal | CHEMICAL | 5 |
| meta | ORG | 5 |
| nps | CHEMICAL | 5 |
| nacl | CHEMICAL | 5 |
| ph | ORG | 5 |
| raas | ORG | 5 |
| rat | TAXON | 5 |
| hyperglycemia | PERSON | 5 |
| sd | DISEASE | 5 |
| iii | ORG | 5 |
| aii | CHEMICAL | 5 |
| hbv | ORG | 5 |
| cvds | DISEASE | 5 |
| sakoda | PERSON | 5 |
| akt | ORG | 5 |
| afatinib | GPE | 5 |
| arrestins | ORG | 5 |
| autophagy | PERSON | 5 |
| cc | CHEMICAL | 5 |
| calcium | ORG | 5 |
| glucose | CHEMICAL | 5 |
| cardiovascular disease | DISEASE | 5 |
| chloroquine | CHEMICAL | 5 |
| dize | ORG | 5 |
| diabetic | LOC | 5 |
| differential | ORG | 5 |
| glomerulosclerosis | GPE | 5 |
| sry | ORG | 5 |
| potassium wasting | CHEMICAL | 5 |
| sorafenib | PERSON | 5 |
| renal hypertrophy | DISEASE | 5 |
| leucine | CHEMICAL | 5 |
| lung inflammation | DISEASE | 5 |
| mammals | TAXON | 5 |
| man | TAXON | 5 |
| platelet aggregation | DISEASE | 5 |
| pulmonary fibrosis | DISEASE | 5 |
| respiratory syndrome coronavirus sars | DISEASE | 5 |
| hydroxychloroquine | CHEMICAL | 5 |
| retinopathy | DISEASE | 5 |
| systolic dysfunction | DISEASE | 5 |
| tissue damage | DISEASE | 5 |
| toxicity | DISEASE | 5 |
| tumour necrosis | DISEASE | 5 |
| tnbs | GPE | 5 |
| hypertensives | DISEASE | 5 |
| renal damage | DISEASE | 5 |
| human homolog | TAXON | 5 |
| cleft | DISEASE | 5 |
| tumor necrosis | DISEASE | 5 |
| host cell | TAXON | 5 |
| adenocarcinoma | DISEASE | 5 |
| angiotensin 1 7 forming enzymes | CHEMICAL | 5 |
| angiotensin type 2 receptor | CHEMICAL | 5 |
| cardiac fibrosis | DISEASE | 5 |
| chronic heart failure | DISEASE | 5 |
| azithromycin | CHEMICAL | 5 |
| eplerenone | CHEMICAL | 5 |
| estrogens | CHEMICAL | 5 |
| glomerular injury | DISEASE | 5 |
| glomerulopathy | DISEASE | 5 |
| hexose | CHEMICAL | 5 |
| histidine | CHEMICAL | 5 |
| sars cov | DISEASE | 4 |
| pneumonia | GPE | 4 |
| saax | ORG | 4 |
| saa | ORG | 4 |
| renin angiotensin | PERSON | 4 |
| raf 1 | PERSON | 4 |
| rvlm | ORG | 4 |
| podocytes | ORG | 4 |
| microsoft | ORG | 4 |
| pavenstadt | CHEMICAL | 4 |
| ovx | ORG | 4 |
| osu | ORG | 4 |
| nsclc | ORG | 4 |
| nafld | ORG | 4 |
| murine | TAXON | 4 |
| mouse | TAXON | 4 |
| mst3 | PERSON | 4 |
| sky54 | CHEMICAL | 4 |
| shrsp | ORG | 4 |
| al 2013 | PERSON | 4 |
| snp | ORG | 4 |
| src | ORG | 4 |
| angiotensine | CHEMICAL | 4 |
| angiotensin 1 9 a | CHEMICAL | 4 |
| angiotensin 1 7 or | CHEMICAL | 4 |
| lisinopril | CHEMICAL | 4 |
| acute respiratory syndrome coronavirus 2 sars cov | DISEASE | 4 |
| acute respiratory syndrome coronavirus | DISEASE | 4 |
| acute respiratory syndrome sars | DISEASE | 4 |
| acute coronary syndrome | DISEASE | 4 |
| united states | GPE | 4 |
| uc | DISEASE | 4 |
| thrombosis | DISEASE | 4 |
| telmisartan | CHEMICAL | 4 |
| tt | ORG | 4 |
| tnfalpha | ORG | 4 |
| tg | GPE | 4 |
| statins | ORG | 4 |
| sildenafil | CHEMICAL | 4 |
| mda | ORG | 4 |
| dengue | TAXON | 4 |
| lps | ORG | 4 |
| cholesterol | ORG | 4 |
| cyh | ORG | 4 |
| cxcl16 | ORG | 4 |
| ccr | ORG | 4 |
| bowman | ORG | 4 |
| bip | ORG | 4 |
| bamhi | PERSON | 4 |
| axis | DISEASE | 4 |
| angiotensin iii | PERSON | 4 |
| ang ii ang | PERSON | 4 |
| ave0991 | PERSON | 4 |
| at1a | GPE | 4 |
| ang iv | PERSON | 4 |
| ali | ORG | 4 |
| ace d | CHEMICAL | 4 |
| ace 2 expression | CHEMICAL | 4 |
| 5foa | ORG | 4 |
| ascites | DISEASE | 4 |
| cardiovascular disease | DISEASE | 4 |
| clostridium | ORG | 4 |
| kriz | PERSON | 4 |
| dad | ORG | 4 |
| ifn | ORG | 4 |
| hypokalaemia | DISEASE | 4 |
| h7n9 | GPE | 4 |
| gln | CHEMICAL | 4 |
| genetic ace2 | ORG | 4 |
| gastrin | ORG | 4 |
| grpr | ORG | 4 |
| gi | ORG | 4 |
| fp | ORG | 4 |
| ffas | CHEMICAL | 4 |
| estradiol | GPE | 4 |
| entresto | ORG | 4 |
| endothelin | GPE | 4 |
| durvasula | PERSON | 4 |
| dahl | GPE | 4 |
| dkd | CHEMICAL | 4 |
| daf | ORG | 4 |
| aorta | GPE | 4 |
| scfa | CHEMICAL | 4 |
| asthma | DISEASE | 4 |
| proline | CHEMICAL | 4 |
| porcine | TAXON | 4 |
| podocin | CHEMICAL | 4 |
| plaque | DISEASE | 4 |
| phosphate | CHEMICAL | 4 |
| phenylalanine | CHEMICAL | 4 |
| pazopanib | CHEMICAL | 4 |
| pancreatic cancer | DISEASE | 4 |
| organ dysfunction | DISEASE | 4 |
| norepinephrine | CHEMICAL | 4 |
| nicotinamide adenine | ORG | 4 |
| necrosis | DISEASE | 4 |
| myocardial ischemia | DISEASE | 4 |
| myocardial dysfunction | DISEASE | 4 |
| muscle weakness | DISEASE | 4 |
| mouse podocytes | TAXON | 4 |
| mmhg | ORG | 4 |
| microalbuminuria | DISEASE | 4 |
| posturing | DISEASE | 4 |
| pulmonary arterial hypertension | DISEASE | 4 |
| lung adenocarcinomas | DISEASE | 4 |
| pulmonary disease | DISEASE | 4 |
| yeasts | TAXON | 4 |
| virus cell | TAXON | 4 |
| viral pneumonia | DISEASE | 4 |
| ventricular dysfunction | DISEASE | 4 |
| vascular senescence | DISEASE | 4 |
| vascular inflammation | DISEASE | 4 |
| vascular damage | DISEASE | 4 |
| vascular complications | DISEASE | 4 |
| uracil | CHEMICAL | 4 |
| tubulopathy | DISEASE | 4 |
| trypsin | CHEMICAL | 4 |
| the sars cov 2 | ORG | 4 |
| septic shock | DISEASE | 4 |
| salt | CHEMICAL | 4 |
| renal impairment | DISEASE | 4 |
| renal dysfunction | DISEASE | 4 |
| rat podocytes | TAXON | 4 |
| lupus nephritis | DISEASE | 4 |
| saralasin | CHEMICAL | 4 |
| liver injury | DISEASE | 4 |
| epinephrine | CHEMICAL | 4 |
| dog | TAXON | 4 |
| dipeptide | CHEMICAL | 4 |
| diabetic kidney disease | DISEASE | 4 |
| diabetic cardiovascular complications | DISEASE | 4 |
| diabetic angiotensin ii | DISEASE | 4 |
| depressed | DISEASE | 4 |
| dementia | DISEASE | 4 |
| dehydration | DISEASE | 4 |
| critically ill | DISEASE | 4 |
| coronavirus infected pneumonia | DISEASE | 4 |
| chronic diseases | DISEASE | 4 |
| cardiovascular dysfunction | DISEASE | 4 |
| cardiovascular complications | DISEASE | 4 |
| cardiomyopathy | DISEASE | 4 |
| breast cancer | DISEASE | 4 |
| bat | TAXON | 4 |
| ischaemia | DISEASE | 4 |
| dogs | TAXON | 4 |
| chronic hepatitis c | DISEASE | 4 |
| focal segmental glomerulosclerosis | DISEASE | 4 |
| host cells | TAXON | 4 |
| irbesartan | CHEMICAL | 4 |
| avian | TAXON | 4 |
| inflammatory diseases | DISEASE | 4 |
| infarction | DISEASE | 4 |
| hypokalaemic | DISEASE | 4 |
| hypercapnia | GPE | 4 |
| human coronavirus nl63 | TAXON | 4 |
| human cells | TAXON | 4 |
| hypertensin | CHEMICAL | 4 |
| heparan sulfate | CHEMICAL | 4 |
| goat | TAXON | 4 |
| glomerulonephritis | DISEASE | 4 |
| glomeruli | GPE | 4 |
| glomerular hypertrophy | DISEASE | 4 |
| fracture | DISEASE | 4 |
| gut dysbiosis | DISEASE | 4 |
| furin | ORG | 4 |
| new york city | GPE | 3 |
| nad p h | ORG | 3 |
| nts | ORG | 3 |
| na k | CHEMICAL | 3 |
| neprilysin | GPE | 3 |
| opg | ORG | 3 |
| newcastle | GPE | 3 |
| notch | ORG | 3 |
| orx h | ORG | 3 |
| pgc | CHEMICAL | 3 |
| mehta et al 90 | PERSON | 3 |
| occam s razor | ORG | 3 |
| molecular | GPE | 3 |
| latinos | ORG | 3 |
| mechanisms | ORG | 3 |
| mammalian | TAXON | 3 |
| malaria | TAXON | 3 |
| mst4 | CHEMICAL | 3 |
| lung cancer | ORG | 3 |
| lipopolysaccharide | CHEMICAL | 3 |
| liebau | PERSON | 3 |
| ldlr | PERSON | 3 |
| ln | GPE | 3 |
| les | ORG | 3 |
| krebs | PERSON | 3 |
| potassium | CHEMICAL | 3 |
| kawasaki | ORG | 3 |
| pjs | ORG | 3 |
| tumors | DISEASE | 3 |
| qiu | PERSON | 3 |
| raf | PERSON | 3 |
| insulin | PERSON | 3 |
| ypg | PERSON | 3 |
| ypd | ORG | 3 |
| x | PERSON | 3 |
| wolf | PERSON | 3 |
| williams | PERSON | 3 |
| vitro | GPE | 3 |
| vascular inflammation | ORG | 3 |
| tris | PERSON | 3 |
| toll | PERSON | 3 |
| threonine | CHEMICAL | 3 |
| tf | ORG | 3 |
| tams | CHEMICAL | 3 |
| small cell lung cancer | DISEASE | 3 |
| signal | ORG | 3 |
| sidak | ORG | 3 |
| sv40 | TAXON | 3 |
| sox3 | ORG | 3 |
| sky191 | CHEMICAL | 3 |
| sign | CHEMICAL | 3 |
| sars coronavirus infection | DISEASE | 3 |
| sars cov 2 infection | DISEASE | 3 |
| rats | TAXON | 3 |
| ras raf | ORG | 3 |
| ras | PERSON | 3 |
| japan | GPE | 3 |
| bmd | ORG | 3 |
| influenza | ORG | 3 |
| apoptosis | GPE | 3 |
| cre | LOC | 3 |
| ceramide | CHEMICAL | 3 |
| csk | ORG | 3 |
| covid infection | DISEASE | 3 |
| covid 19 sars cov 2 | ORG | 3 |
| cns | ORG | 3 |
| ccl | CHEMICAL | 3 |
| brain | GPE | 3 |
| bombesin | GPE | 3 |
| zhang et al 56 | PERSON | 3 |
| bbb | ORG | 3 |
| bay | CHEMICAL | 3 |
| antisense | ORG | 3 |
| infection | DISEASE | 3 |
| angiotensin 1 7 | LOC | 3 |
| angioedema | ORG | 3 |
| abdominal aortic aneurysm | DISEASE | 3 |
| atr12181 | PERSON | 3 |
| atii | ORG | 3 |
| arb losartan | CHEMICAL | 3 |
| app | ORG | 3 |
| ace inhibitor captopril | CHEMICAL | 3 |
| ace gene polymorphisms | CHEMICAL | 3 |
| ace ang ii at | CHEMICAL | 3 |
| ace ace 2 imbalance | CHEMICAL | 3 |
| ace 2 activity | CHEMICAL | 3 |
| crohn | PERSON | 3 |
| crohn s colitis | DISEASE | 3 |
| cterminus | ORG | 3 |
| diarrhea | PERSON | 3 |
| igg | ORG | 3 |
| il 4 | ORG | 3 |
| il 24 | ORG | 3 |
| il 1 | ORG | 3 |
| ibv | ORG | 3 |
| iay | ORG | 3 |
| humans | TAXON | 3 |
| hong kong | GPE | 3 |
| hartnup | PERSON | 3 |
| hsc | ORG | 3 |
| ho | CHEMICAL | 3 |
| hivan | ORG | 3 |
| h1975 | ORG | 3 |
| gut microbiota | PERSON | 3 |
| guanine | CHEMICAL | 3 |
| glomerular | PERSON | 3 |
| gm | ORG | 3 |
| furin | ORG | 3 |
| flt1 | GPE | 3 |
| fischer | GPE | 3 |
| fabry | PERSON | 3 |
| fps | CHEMICAL | 3 |
| endothelial dysfunction | DISEASE | 3 |
| eae | ORG | 3 |
| diminazene | ORG | 3 |
| zhang et al 2015b | PERSON | 3 |
| neutrophil | GPE | 3 |
| acetylcholine | CHEMICAL | 3 |
| metabolism disorder | DISEASE | 3 |
| preeclampsia | DISEASE | 3 |
| pig | TAXON | 3 |
| penicillamine | CHEMICAL | 3 |
| pathologies | DISEASE | 3 |
| oestrogen | CHEMICAL | 3 |
| normokalaemia | DISEASE | 3 |
| nicotinamide adenine dinucleotide phosphate nadph | CHEMICAL | 3 |
| neointima | CHEMICAL | 3 |
| ncov infected | DISEASE | 3 |
| myocardial injury | DISEASE | 3 |
| microvascular thrombosis | DISEASE | 3 |
| microvascular complications | ORG | 3 |
| mammalian cells | TAXON | 3 |
| prostate cancer | DISEASE | 3 |
| lung injuries | DISEASE | 3 |
| lipotoxicity | DISEASE | 3 |
| lamina propria mesenchymal | PERSON | 3 |
| kidney injuries | DISEASE | 3 |
| kidney diseases | DISEASE | 3 |
| journal | ORG | 3 |
| ischemic stroke | DISEASE | 3 |
| intestinal inflammation | DISEASE | 3 |
| inflammatory lung disease | DISEASE | 3 |
| inflammatory bowel disease | DISEASE | 3 |
| infected | DISEASE | 3 |
| infarct | DISEASE | 3 |
| prorénine | CHEMICAL | 3 |
| pulmonary damage | DISEASE | 3 |
| hydrogen | CHEMICAL | 3 |
| valsartan | CHEMICAL | 3 |
| adiponectin | CHEMICAL | 3 |
| β arrestin | PERSON | 3 |
| yeast cells | TAXON | 3 |
| virus membrane | TAXON | 3 |
| viral destruction | DISEASE | 3 |
| viral cell | TAXON | 3 |
| ventricular hypertrophy | DISEASE | 3 |
| ventricular fibrillation | DISEASE | 3 |
| vascular smooth muscle cell | DISEASE | 3 |
| vascular injury | DISEASE | 3 |
| vascular dysfunction | DISEASE | 3 |
| vascular diseases | DISEASE | 3 |
| ursodeoxycholic acid | CHEMICAL | 3 |
| rapamycin | CHEMICAL | 3 |
| type 2 diabetic | DISEASE | 3 |
| the world health organization | ORG | 3 |
| the sars cov | ORG | 3 |
| sodium chloride | CHEMICAL | 3 |
| sialic acid | CHEMICAL | 3 |
| sheep | TAXON | 3 |
| respiratory syndrome coronavirus infection | DISEASE | 3 |
| respiratory infections | DISEASE | 3 |
| respiratory failure | DISEASE | 3 |
| renin prorenin | PERSON | 3 |
| renal failure | DISEASE | 3 |
| renal fanconi syndrome | DISEASE | 3 |
| hypertrophy myocardial fibrosis | DISEASE | 3 |
| rhodamine | CHEMICAL | 3 |
| human diseases | DISEASE | 3 |
| apolipoprotein e | DISEASE | 3 |
| cardiac failure | DISEASE | 3 |
| cardiac disease | DISEASE | 3 |
| cardiac death | DISEASE | 3 |
| cardiac arrest | DISEASE | 3 |
| bovine | TAXON | 3 |
| bone marrow dysfunction | DISEASE | 3 |
| blood cancer | DISEASE | 3 |
| bladder cancer | DISEASE | 3 |
| autonomic dysfunction | DISEASE | 3 |
| atrial fibrillation | DISEASE | 3 |
| atenolol | CHEMICAL | 3 |
| arrhythmias | DISEASE | 3 |
| angiotensins | CHEMICAL | 3 |
| cell damage | DISEASE | 3 |
| angiotensinaldosterone | CHEMICAL | 3 |
| angiotensin iimediated | CHEMICAL | 3 |
| angiotensin iii | PERSON | 3 |
| angiotensin angiotensin | CHEMICAL | 3 |
| angiotensin ang ii | PERSON | 3 |
| angiotensin 1 7 receptor mas | CHEMICAL | 3 |
| angiotensin 1 7 in | CHEMICAL | 3 |
| angiotensin 1 7 a | CHEMICAL | 3 |
| angiotensin 1 7 mas | CHEMICAL | 3 |
| alcohol | CHEMICAL | 3 |
| human disease | DISEASE | 3 |
| al 2014 | PERSON | 3 |
| cardiovascular and renal physiology | DISEASE | 3 |
| angiotensin iv | CHEMICAL | 3 |
| cerebral artery occlusion | DISEASE | 3 |
| diarrhea | PERSON | 3 |
| hepatic fibrosis | DISEASE | 3 |
| gut syndrome | DISEASE | 3 |
| cerebral ischemia | DISEASE | 3 |
| gastric inflammation | DISEASE | 3 |
| gastric cancer | DISEASE | 3 |
| gallate | CHEMICAL | 3 |
| galactose | CHEMICAL | 3 |
| fibrogenesis | DISEASE | 3 |
| eprosartan | CHEMICAL | 3 |
| epilepsy | DISEASE | 3 |
| electron | ORG | 3 |
| dilated cardiomyopathy | DISEASE | 3 |
| diastolic dysfunction | DISEASE | 3 |
| fmlp | CHEMICAL | 3 |
| diabetic nephropathy angiotensin | DISEASE | 3 |
| coronavirus nl63 | DISEASE | 3 |
| diabetic kidney injury | DISEASE | 3 |
| coagulopathy | DISEASE | 3 |
| coronavirus 2019 ncov sars cov | DISEASE | 3 |
| coronavirus sars | DISEASE | 3 |
| coronaviruses | TAXON | 3 |
| deoxycorticosterone | CHEMICAL | 3 |
| diabetic cardiomyopathy | DISEASE | 3 |
| cirrhotic liver | DISEASE | 3 |
| complexity | DISEASE | 3 |
| luminal | ORG | 2 |
| liver disease | DISEASE | 2 |
| liver | LOC | 2 |
| lcz696 | PERSON | 2 |
| lewis | PERSON | 2 |
| lessons | ORG | 2 |
| life | ORG | 2 |
| klotho | ORG | 2 |
| l name | CHEMICAL | 2 |
| kolivras | PERSON | 2 |
| km | PERSON | 2 |
| kip1 | ORG | 2 |
| kinin | ORG | 2 |
| kch | ORG | 2 |
| kallikreinkinin | TAXON | 2 |
| map3k | PERSON | 2 |
| kaysen 2001 | LOC | 2 |
| lys pro | PERSON | 2 |
| metastasis | DISEASE | 2 |
| mcd | ORG | 2 |
| md usa | ORG | 2 |
| nct04311177 | CHEMICAL | 2 |
| nct04330300 | GPE | 2 |
| k ras | ORG | 2 |
| ncc ncc | ORG | 2 |
| mrgd | CHEMICAL | 2 |
| mol med berl | PERSON | 2 |
| mitochondria | GPE | 2 |
| micro | LOC | 2 |
| marfan | GPE | 2 |
| magee | PERSON | 2 |
| macrophage | ORG | 2 |
| macconi | PERSON | 2 |
| mufas | CHEMICAL | 2 |
| mme | ORG | 2 |
| mip | ORG | 2 |
| met | DISEASE | 2 |
| mek2 | CHEMICAL | 2 |
| kc hart | ORG | 2 |
| henle | PERSON | 2 |
| johns hopkins university school of medicine | ORG | 2 |
| hartnup disorder | DISEASE | 2 |
| hippuryl | CHEMICAL | 2 |
| heymann nephritis | DISEASE | 2 |
| heymann | PERSON | 2 |
| hepatic | LOC | 2 |
| hemnes | PERSON | 2 |
| heart disease | DISEASE | 2 |
| heart failure | DISEASE | 2 |
| hxt | ORG | 2 |
| huang | PERSON | 2 |
| hts | ORG | 2 |
| hmgcr | ORG | 2 |
| hiv virus | TAXON | 2 |
| hg | ORG | 2 |
| hfpef | DISEASE | 2 |
| nrti | ORG | 2 |
| hdac | ORG | 2 |
| hras | PERSON | 2 |
| hubei | GPE | 2 |
| janus | GPE | 2 |
| itp | ORG | 2 |
| jg | GPE | 2 |
| invitrogen usa | ORG | 2 |
| intracellular | ORG | 2 |
| interactions | ORG | 2 |
| ink4a attac | CHEMICAL | 2 |
| ink4a | GPE | 2 |
| immune | LOC | 2 |
| irs | ORG | 2 |
| hydroxychloroquine | CHEMICAL | 2 |
| ipp | ORG | 2 |
| ip3 | CHEMICAL | 2 |
| ink4a | CHEMICAL | 2 |
| imn | ORG | 2 |
| il 1 ri | PERSON | 2 |
| hypokalemia | ORG | 2 |
| hypertensive | DISEASE | 2 |
| nqo | ORG | 2 |
| scap | ORG | 2 |
| nagata 2016 | PERSON | 2 |
| sars cov 1 | ORG | 2 |
| serms | CHEMICAL | 2 |
| sasp | ORG | 2 |
| sars coronavirus sars cov | DISEASE | 2 |
| sars coronavirus a | DISEASE | 2 |
| sars cov infections | DISEASE | 2 |
| sars cov sars cov 2 | ORG | 2 |
| sars cov sars cov | ORG | 2 |
| s6ki | CHEMICAL | 2 |
| sle | DISEASE | 2 |
| rho | PERSON | 2 |
| review | ORG | 2 |
| responses | ORG | 2 |
| respiratory syndrome sars | DISEASE | 2 |
| respiratory syndrome coronavirus infection | DISEASE | 2 |
| respiratory distress syndrome | DISEASE | 2 |
| reninangiotensin | PERSON | 2 |
| sfa | ORG | 2 |
| smm | ORG | 2 |
| renin angiotensin aldosterone system | PERSON | 2 |
| ser thr | PERSON | 2 |
| hat | ORG | 2 |
| stroke | DISEASE | 2 |
| south korea | GPE | 2 |
| smad | ORG | 2 |
| single | ORG | 2 |
| sigmund | ORG | 2 |
| shimada | GPE | 2 |
| ser asp lys pro | PERSON | 2 |
| saccharomyces | CHEMICAL | 2 |
| ser asp | PERSON | 2 |
| sensitivity | PERSON | 2 |
| seliga | GPE | 2 |
| selective | ORG | 2 |
| saudi arabia | GPE | 2 |
| santa cruz usa | GPE | 2 |
| salt | ORG | 2 |
| renin r | PERSON | 2 |
| remdesivir | PERSON | 2 |
| nampt | PERSON | 2 |
| nsp12 | CHEMICAL | 2 |
| pka | ORG | 2 |
| ph copd | ORG | 2 |
| pdr | ORG | 2 |
| pcp | ORG | 2 |
| pbs | ORG | 2 |
| osteoporosis | ORG | 2 |
| nterminus | ORG | 2 |
| nox2 | ORG | 2 |
| pra | ORG | 2 |
| nox1 | ORG | 2 |
| nox | ORG | 2 |
| nestin | GPE | 2 |
| neprilysin nep | PERSON | 2 |
| nephropathy | PERSON | 2 |
| nephrin | PERSON | 2 |
| nefin | ORG | 2 |
| ppar | ORG | 2 |
| prism | CHEMICAL | 2 |
| recombinant | ORG | 2 |
| qiaamp | ORG | 2 |
| ramipril | CHEMICAL | 2 |
| rac1 | GPE | 2 |
| rabbit | TAXON | 2 |
| ras overactivation | DISEASE | 2 |
| ras modulator | ORG | 2 |
| ras imbalance | DISEASE | 2 |
| raf 1 | PERSON | 2 |
| prendergast | ORG | 2 |
| psp | ORG | 2 |
| podocyte | LOC | 2 |
| plasmodium | TAXON | 2 |
| phillips | PERSON | 2 |
| philip cohen | PERSON | 2 |
| peng | PERSON | 2 |
| pao | ORG | 2 |
| pten | ORG | 2 |
| hbeag | CHEMICAL | 2 |
| 1 ang ii | PERSON | 2 |
| h ras | ORG | 2 |
| angiotensinconverting | ORG | 2 |
| bacteroides | GPE | 2 |
| bdl | ORG | 2 |
| arrhythmien | PERSON | 2 |
| arrhythmias | ORG | 2 |
| arrestin | PERSON | 2 |
| arabia | TAXON | 2 |
| animals | TAXON | 2 |
| angiotensin peptides | CHEMICAL | 2 |
| behavioural | ORG | 2 |
| angiotensin receptor | PERSON | 2 |
| angiotensin ii nadph | CHEMICAL | 2 |
| angiotensin ii ang ii | PERSON | 2 |
| angiotensin i | CHEMICAL | 2 |
| angiotensin converting enzyme inhibitors | ORG | 2 |
| angiotensin at1 | PERSON | 2 |
| angii at 1 r | CHEMICAL | 2 |
| banas | ORG | 2 |
| beijing | GPE | 2 |
| ang ii ang iii | PERSON | 2 |
| cd10 | ORG | 2 |
| cxcr | ORG | 2 |
| ctgf | ORG | 2 |
| crp | ORG | 2 |
| cq hcq | CHEMICAL | 2 |
| cq | CHEMICAL | 2 |
| covid 19 organ damage | DISEASE | 2 |
| cd95 | CHEMICAL | 2 |
| ccl4 | CHEMICAL | 2 |
| beneficial | ORG | 2 |
| ccl | ORG | 2 |
| car | ORG | 2 |
| breast cancer | DISEASE | 2 |
| bone | ORG | 2 |
| boehringer mannheim | ORG | 2 |
| blockade | ORG | 2 |
| blautia roseburia | GPE | 2 |
| ang iv fig | PERSON | 2 |
| ang ii ang ii | PERSON | 2 |
| cacl2 | ORG | 2 |
| ace deficiency | DISEASE | 2 |
| ace2 | CHEMICAL | 2 |
| acv | ORG | 2 |
| ace polymorphism 61 | CHEMICAL | 2 |
| ace inhibitors acei | CHEMICAL | 2 |
| ace inhibitor perindopril | CHEMICAL | 2 |
| ace inhibitor acei | CHEMICAL | 2 |
| ace imbalance | CHEMICAL | 2 |
| ace ras | ORG | 2 |
| aki | DISEASE | 2 |
| ace angiotensin | CHEMICAL | 2 |
| ace 2 a | CHEMICAL | 2 |
| ace 2 that | CHEMICAL | 2 |
| ace 2 ang 1 7 | CHEMICAL | 2 |
| ac n | ORG | 2 |
| abc | ORG | 2 |
| t1d | DISEASE | 2 |
| adp | ORG | 2 |
| anova | ORG | 2 |
| ang i | ORG | 2 |
| agrp | GPE | 2 |
| ang 1 2 | PERSON | 2 |
| anesthesia | GPE | 2 |
| androgens | ORG | 2 |
| analysis | PERSON | 2 |
| alzheimer disease | DISEASE | 2 |
| alport syndrome | DISEASE | 2 |
| agouti | PERSON | 2 |
| adipose | ORG | 2 |
| arbs | ORG | 2 |
| adenosine | ORG | 2 |
| acute | ORG | 2 |
| acetylcholine | CHEMICAL | 2 |
| acetate | ORG | 2 |
| aatii saci | ORG | 2 |
| aatii | PERSON | 2 |
| avp | ORG | 2 |
| ca2 | CHEMICAL | 2 |
| california | GPE | 2 |
| gupta | PERSON | 2 |
| ethanol | PERSON | 2 |
| fawn | PERSON | 2 |
| fanconi | PERSON | 2 |
| fabry disease | DISEASE | 2 |
| fsp | ORG | 2 |
| ffa | CHEMICAL | 2 |
| ezrin | ORG | 2 |
| expression of | ORG | 2 |
| epub | PERSON | 2 |
| gal1 | ORG | 2 |
| epinephrine | CHEMICAL | 2 |
| epidemiological | ORG | 2 |
| enteric | DISEASE | 2 |
| ecklonia | GPE | 2 |
| eta | ORG | 2 |
| et 1 | ORG | 2 |
| erbb | ORG | 2 |
| france | GPE | 2 |
| gfr | ORG | 2 |
| enac | PERSON | 2 |
| gender differences | PERSON | 2 |
| gomez | CHEMICAL | 2 |
| goldwich | PERSON | 2 |
| gly | CHEMICAL | 2 |
| glutamine | PERSON | 2 |
| glucagon | GPE | 2 |
| gln37 ile | PERSON | 2 |
| genotype | PERSON | 2 |
| gefitinib gefitinib | PERSON | 2 |
| gip | PERSON | 2 |
| gefitinib | CHEMICAL | 2 |
| gastrointestinal complications | ORG | 2 |
| gtpase and nucleotide exchange | ORG | 2 |
| gtpase rac1 | ORG | 2 |
| gpi | ORG | 2 |
| gnm | ORG | 2 |
| gmp | PERSON | 2 |
| er | GPE | 2 |
| drosophila | GPE | 2 |
| careful | GPE | 2 |
| cloning | PERSON | 2 |
| corynebacterium papillomavirus | TAXON | 2 |
| coronaviruses | TAXON | 2 |
| coronavirus sars cov | DISEASE | 2 |
| coronaviridae | ORG | 2 |
| collectrin | PERSON | 2 |
| colesevelam | PERSON | 2 |
| cov infection | DISEASE | 2 |
| clinicaltrial | ORG | 2 |
| covid 19 renin | ORG | 2 |
| chymase | PERSON | 2 |
| chronic pulmonary disease | DISEASE | 2 |
| china structural | ORG | 2 |
| central | ORG | 2 |
| cellesi | ORG | 2 |
| celecoxib | CHEMICAL | 2 |
| catecholamines | CHEMICAL | 2 |
| covid 19 | ORG | 2 |
| coward et al 2005 coward et al 2007 | ORG | 2 |
| down | DISEASE | 2 |
| dj donoghue | ORG | 2 |
| diminazene aceturate | CHEMICAL | 2 |
| dexamethasone | ORG | 2 |
| davisson | PERSON | 2 |
| dan ding yimei du | PERSON | 2 |
| dss colitis | CHEMICAL | 2 |
| dn | GPE | 2 |
| dm dm | ORG | 2 |
| dc | GPE | 2 |
| crowley | PERSON | 2 |
| david | ORG | 2 |
| dag | ORG | 2 |
| cytoscape | GPE | 2 |
| cyclic nucleotides | PERSON | 2 |
| curcumin epigallocatechin | PERSON | 2 |
| crystal | ORG | 2 |
| cryo em | PERSON | 2 |
| structure | ORG | 2 |
| selçuk et al 81 | PERSON | 2 |
| tace adam 17 | ORG | 2 |
| pulmonary edema | DISEASE | 2 |
| organ failure | DISEASE | 2 |
| olmesartan medoxomil | PERSON | 2 |
| oleic acid | CHEMICAL | 2 |
| oedema | DISEASE | 2 |
| obesity diabetes | DISEASE | 2 |
| nonalcoholic steatohepatitis | DISEASE | 2 |
| nicotinamideadenine dinucleotide phosphate | CHEMICAL | 2 |
| neutral amino acids | CHEMICAL | 2 |
| neurotensin | CHEMICAL | 2 |
| neuropeptide | CHEMICAL | 2 |
| neurogenic hypertension | DISEASE | 2 |
| neratinib sorafenib | PERSON | 2 |
| nephron degeneration | DISEASE | 2 |
| nematode | TAXON | 2 |
| myocardial infarction angiotensin | DISEASE | 2 |
| myocardial hypertrophy | DISEASE | 2 |
| myalgia | DISEASE | 2 |
| organs damage | DISEASE | 2 |
| osteoprotegerin opg | ORG | 2 |
| overactive | DISEASE | 2 |
| proangiotensin | CHEMICAL | 2 |
| pulmonary complications | DISEASE | 2 |
| pseudocysts | DISEASE | 2 |
| protracted illness | DISEASE | 2 |
| proteotoxic | ORG | 2 |
| proteinuria glomerulosclerosis | DISEASE | 2 |
| prostaglandins | CHEMICAL | 2 |
| prorenin prorenin | CHEMICAL | 2 |
| polyols | CHEMICAL | 2 |
| pain | DISEASE | 2 |
| polymyxin b sulfate | CHEMICAL | 2 |
| polymyxin b nonapeptide | CHEMICAL | 2 |
| pleural effusions | DISEASE | 2 |
| plasma membrane | PERSON | 2 |
| peroxynitrite | CHEMICAL | 2 |
| peptide formyl met leu phe fmlp | CHEMICAL | 2 |
| paraesthesia thirst muscle cramps | ORG | 2 |
| muscularis propria | PERSON | 2 |
| muscularis mucosa | PERSON | 2 |
| muscle weakness paraesthesia thirst muscle cramps | DISEASE | 2 |
| inflammatory injury | DISEASE | 2 |
| ischaemic stroke | DISEASE | 2 |
| ischaemic | DISEASE | 2 |
| intestinal type gastric cancer | DISEASE | 2 |
| intestinal mucosal acidosis | DISEASE | 2 |
| intestinal ischaemia | DISEASE | 2 |
| interstitial oedema | DISEASE | 2 |
| inflammatory thrombocytosis | DISEASE | 2 |
| infectious diseases | DISEASE | 2 |
| kinins | CHEMICAL | 2 |
| infectious disease | DISEASE | 2 |
| infectious bronchitis | DISEASE | 2 |
| incretin | PERSON | 2 |
| impairment | DISEASE | 2 |
| immune disorder | DISEASE | 2 |
| ibuprofen | CHEMICAL | 2 |
| hypovolemia | DISEASE | 2 |
| kidney damage | DISEASE | 2 |
| lamina propria | PERSON | 2 |
| motility disorders | DISEASE | 2 |
| memory loss | DISEASE | 2 |
| monocrotaline | CHEMICAL | 2 |
| microbial infection | DISEASE | 2 |
| mice prorenin receptor | TAXON | 2 |
| methanol | CHEMICAL | 2 |
| metabolic disorders | DISEASE | 2 |
| metabolic diseases | DISEASE | 2 |
| mesenteric ischaemia | DISEASE | 2 |
| melanoma | DISEASE | 2 |
| learning deficits | DISEASE | 2 |
| mas | ORG | 2 |
| malignant disease | DISEASE | 2 |
| lysophospholipids | CHEMICAL | 2 |
| lung diseases | DISEASE | 2 |
| loss of bone mass | DISEASE | 2 |
| lipopolysaccharides | CHEMICAL | 2 |
| linker derivatives | PERSON | 2 |
| pulmonary dysfunction | DISEASE | 2 |
| pulmonary inflammation | DISEASE | 2 |
| hypotensive | DISEASE | 2 |
| pulmonary insult | DISEASE | 2 |
| vascular pathologies | DISEASE | 2 |
| vascular insult | DISEASE | 2 |
| vascular endothelial dysfunction | DISEASE | 2 |
| uremia | DISEASE | 2 |
| urea nitrogen | PERSON | 2 |
| urea | CHEMICAL | 2 |
| type 1 diabetes | DISEASE | 2 |
| tubular injury | DISEASE | 2 |
| tubular damage | DISEASE | 2 |
| tryptophan glutamine | PERSON | 2 |
| trisphosphate | CHEMICAL | 2 |
| triglycerides | CHEMICAL | 2 |
| triglyceride | CHEMICAL | 2 |
| transgenic | ORG | 2 |
| toxicities | DISEASE | 2 |
| tocilizumab | CHEMICAL | 2 |
| thrombophilia | ORG | 2 |
| vasculitis | DISEASE | 2 |
| venous thromboembolism | DISEASE | 2 |
| viraemia | DISEASE | 2 |
| weakness | DISEASE | 2 |
| β catenin | PERSON | 2 |
| taz | ORG | 2 |
| β mhc | PERSON | 2 |
| yeast membranes | TAXON | 2 |
| yeast saccharomyces cerevisiae | TAXON | 2 |
| xenograft | TAXON | 2 |
| weight loss | DISEASE | 2 |
| volume induced lung injury | DISEASE | 2 |
| viral sars | DISEASE | 2 |
| vitamin d deficiency | CHEMICAL | 2 |
| virus infections | DISEASE | 2 |
| virus disease | DISEASE | 2 |
| viral proteins | TAXON | 2 |
| viral multisystem disease | DISEASE | 2 |
| viral loss | DISEASE | 2 |
| viral diseases | DISEASE | 2 |
| thoracic aortic aneurysm | DISEASE | 2 |
| thirst | DISEASE | 2 |
| thiorphan | CHEMICAL | 2 |
| rhabdomyolysis | DISEASE | 2 |
| skin damages | DISEASE | 2 |
| skeletal muscle atrophy | DISEASE | 2 |
| seryl aspartyl | PERSON | 2 |
| serpentine | CHEMICAL | 2 |
| sarcoidosis | DISEASE | 2 |
| salt hypertensive | CHEMICAL | 2 |
| rs8134378 hypothesizing | PERSON | 2 |
| respiratory virus | TAXON | 2 |
| sodium citrate | CHEMICAL | 2 |
| respiratory syndrome mers | DISEASE | 2 |
| renovascular hypertensive | DISEASE | 2 |
| reduction in pulmonary compliance | DISEASE | 2 |
| reduction in lung compliance | DISEASE | 2 |
| rabbits | TAXON | 2 |
| q7m4srvp | CHEMICAL | 2 |
| pulmonary interstitial oedema | DISEASE | 2 |
| small airways and alveolar trauma | DISEASE | 2 |
| sodium dodecyl sulfate polyacrylamide | CHEMICAL | 2 |
| thiazide | CHEMICAL | 2 |
| suicide | DISEASE | 2 |
| the united states food and drug administration | ORG | 2 |
| the middle east | LOC | 2 |
| the creative commons attribution cc | ORG | 2 |
| the chinese national health commission | ORG | 2 |
| tetrapeptide acsdkp | CHEMICAL | 2 |
| tamoxifen | CHEMICAL | 2 |
| sulphydryl | CHEMICAL | 2 |
| subtypes angii | PERSON | 2 |
| sodium potassium | CHEMICAL | 2 |
| strokes | DISEASE | 2 |
| stress inflammation | DISEASE | 2 |
| streptomycin | CHEMICAL | 2 |
| sterol | CHEMICAL | 2 |
| steroid | CHEMICAL | 2 |
| steatohepatitis | DISEASE | 2 |
| statin | CHEMICAL | 2 |
| hypovolaemia | DISEASE | 2 |
| testosterone deficiency | DISEASE | 2 |
| hypertriglyceridemia | DISEASE | 2 |
| angiotensin ii angiotensin ii | CHEMICAL | 2 |
| angiotensinconverting enzyme inhibitors | CHEMICAL | 2 |
| angiotensin type 2 receptor angiotensin 1 9 | CHEMICAL | 2 |
| angiotensin converting enzyme ace | ORG | 2 |
| angiotensin iconverting | CHEMICAL | 2 |
| angiotensin iv at | CHEMICAL | 2 |
| angiotensin ii blockade | CHEMICAL | 2 |
| angiotensin ii angiotensin ii | CHEMICAL | 2 |
| angiotensin ii angii | CHEMICAL | 2 |
| aortic stiffness | DISEASE | 2 |
| angiotensin 3 8 hexapeptide ang | CHEMICAL | 2 |
| angiotensin 2 8 heptapeptide ang | CHEMICAL | 2 |
| angiotensin 1 7 receptor subtype | CHEMICAL | 2 |
| angiotensin 1 7 prevents | CHEMICAL | 2 |
| angiotensin 1 7 mas receptor axis | CHEMICAL | 2 |
| angiotensin 1 7 closely | CHEMICAL | 2 |
| angiotensin 1 7 between | CHEMICAL | 2 |
| anxiety | DISEASE | 2 |
| arginine | CHEMICAL | 2 |
| angiotensin 1 7 ang 1 7 acts via | CHEMICAL | 2 |
| betablockers | CHEMICAL | 2 |
| bradykinin b | CHEMICAL | 2 |
| bone injury | DISEASE | 2 |
| bone deteriorations | DISEASE | 2 |
| bombesin | CHEMICAL | 2 |
| blood urea nitrogen | CHEMICAL | 2 |
| blood clotting | DISEASE | 2 |
| bipolar affective disorder | DISEASE | 2 |
| baculovirus | TAXON | 2 |
| arrestin | PERSON | 2 |
| avian coronavirus | TAXON | 2 |
| avian ibv | TAXON | 2 |
| autoimmunity | DISEASE | 2 |
| autoimmune nephritis | DISEASE | 2 |
| atresia | GPE | 2 |
| atherosclerotic disease | DISEASE | 2 |
| arterial hypotension | DISEASE | 2 |
| angiotensin 1 7 mas receptor axis enhances the reparative function | CHEMICAL | 2 |
| angiotensin 1 7 ang 1 7 | CHEMICAL | 2 |
| bucillamine | CHEMICAL | 2 |
| transgenic | ORG | 2 |
| valproic | PERSON | 2 |
| vaccination | ORG | 2 |
| vq | ORG | 2 |
| vpp | ORG | 2 |
| v malhotra | GPE | 2 |
| unger | PERSON | 2 |
| usa | GPE | 2 |
| tocilizumab | PERSON | 2 |
| vitamin d insufficiency | PERSON | 2 |
| tni | ORG | 2 |
| thoracic | GPE | 2 |
| target | ORG | 2 |
| taken | GPE | 2 |
| hypertensive nephropathy | DISEASE | 2 |
| tbst | ORG | 2 |
| tachykinin | PERSON | 2 |
| valproic acid | CHEMICAL | 2 |
| vorinostat | CHEMICAL | 2 |
| aneurysm | DISEASE | 2 |
| aceturate | CHEMICAL | 2 |
| amino acid linker | CHEMICAL | 2 |
| alamandine | CHEMICAL | 2 |
| acute respiratory syndrome coronavirus sars | DISEASE | 2 |
| acute respiratory syndrome coronavirus 2 infection | DISEASE | 2 |
| acute respiratory syndrome sars cov | DISEASE | 2 |
| acute respiratory distress syndrome ards | DISEASE | 2 |
| acute diarrhea | DISEASE | 2 |
| abdominal aortic aneurysm | DISEASE | 2 |
| who | ORG | 2 |
| zucker | GPE | 2 |
| zou | PERSON | 2 |
| yoshikawa | GPE | 2 |
| yap | ORG | 2 |
| wösten van asperen et | PERSON | 2 |
| wnt β | PERSON | 2 |
| wang et al | PERSON | 2 |
| bradykinin bradykinin | CHEMICAL | 2 |
| xi | PERSON | 2 |
| burn | DISEASE | 2 |
| estradiol e2 | PERSON | 2 |
| glutaraldehyde | CHEMICAL | 2 |
| glutamate | CHEMICAL | 2 |
| glucose amino acid | CHEMICAL | 2 |
| glomerulopathies | DISEASE | 2 |
| glomerular injuries | DISEASE | 2 |
| gangliosides | CHEMICAL | 2 |
| ganglioside | CHEMICAL | 2 |
| gain | DISEASE | 2 |
| fractures | DISEASE | 2 |
| formaldehyde | CHEMICAL | 2 |
| fits | DISEASE | 2 |
| fingolimod nct04280588 | ORG | 2 |
| fibrosis inflammation | DISEASE | 2 |
| fibronectin | ORG | 2 |
| feces | TAXON | 2 |
| fatty liver disease | DISEASE | 2 |
| ethyl ester | PERSON | 2 |
| glycerol | CHEMICAL | 2 |
| gut disease | DISEASE | 2 |
| gut disorders gastrointestinal malignancy | DISEASE | 2 |
| hyaluronic acid | CHEMICAL | 2 |
| hypertension hypertension | DISEASE | 2 |
| hypertension heart failure | DISEASE | 2 |
| hyperplasia | DISEASE | 2 |
| camostat mesylate | CHEMICAL | 2 |
| hyperglycaemia | DISEASE | 2 |
| hydroxyproline | CHEMICAL | 2 |
| hydrolyze ang | PERSON | 2 |
| human neutrophils | TAXON | 2 |
| heart disease | DISEASE | 2 |
| human liver disease | DISEASE | 2 |
| human heart failure | DISEASE | 2 |
| human gastrointestinal diseases | DISEASE | 2 |
| hog | TAXON | 2 |
| hexosamines | CHEMICAL | 2 |
| heparin sulfate | PERSON | 2 |
| heart failure hypertension | DISEASE | 2 |
| ethidium bromide | CHEMICAL | 2 |
| hepatitis b | DISEASE | 2 |
| estradiol | CHEMICAL | 2 |
| congestive heart failure | DISEASE | 2 |
| comorbidity | DISEASE | 2 |
| cognitive impairment | DISEASE | 2 |
| coagulation | DISEASE | 2 |
| chronic liver injury | DISEASE | 2 |
| chronic liver disease | DISEASE | 2 |
| cholera | DISEASE | 2 |
| cellular dysfunction | DISEASE | 2 |
| cardiovascular pathologies | DISEASE | 2 |
| cardiovascular hypertrophy | DISEASE | 2 |
| cardiovascular damage | DISEASE | 2 |
| cardiovascular and renal diseases | DISEASE | 2 |
| cardiopulmonary disease | DISEASE | 2 |
| endotoxemia | DISEASE | 2 |
| cancer deaths | DISEASE | 2 |
| carbohydrates | CHEMICAL | 2 |
| carboxy terminal amino acid | CHEMICAL | 2 |
| carcinoma | DISEASE | 2 |
| congenital malformations | DISEASE | 2 |
| catecholamine | CHEMICAL | 2 |
| coronary heart disease | DISEASE | 2 |
| diabetes hypertension | DISEASE | 2 |
| endothelial cell damage | DISEASE | 2 |
| coronavirus 2019 ncov | DISEASE | 2 |
| endothelial damage | DISEASE | 2 |
| diacyl glycerol | CHEMICAL | 2 |
| diabetic mellitus dm | DISEASE | 2 |
| diarrhoea | DISEASE | 2 |
| diabetes mellitus hypertension | DISEASE | 2 |
| diabetic injury | DISEASE | 2 |
| dexamethasone | CHEMICAL | 2 |
| deoxycorticosterone acetate | CHEMICAL | 2 |
| cyclic guanosine | PERSON | 2 |
| critically ill | DISEASE | 2 |
| coronavirus infections | DISEASE | 2 |
| encephalopathy | DISEASE | 2 |
| malignancies | DISEASE | 1 |
| malignant renal carcinoma | DISEASE | 1 |
| malkan umit | CHEMICAL | 1 |
| malaria an epidemiological paradox | ORG | 1 |
| malkan https orcid org 0000 0001 5444 | CHEMICAL | 1 |
| maintains | CHEMICAL | 1 |
| magalhaes | GPE | 1 |
| madison wi | PERSON | 1 |
| macklin china | LOC | 1 |
| machida et al | PERSON | 1 |
| mthfr gene | ORG | 1 |
| mers coronavirus infection | DISEASE | 1 |
| machamer | PERSON | 1 |
| ma et al | PERSON | 1 |
| ma | PERSON | 1 |
| mwf | ORG | 1 |
| mst | ORG | 1 |
| ms 119 | CHEMICAL | 1 |
| mri features frequent convulsive seizures | ORG | 1 |
| mn | ORG | 1 |
| mammalian cells metastatic cells are preferentially vulnerable | ORG | 1 |
| mln4760 | CHEMICAL | 1 |
| metavir | ORG | 1 |
| mlcp | ORG | 1 |
| mammalian cells | TAXON | 1 |
| mas tumor | PERSON | 1 |
| mammalian ras | LOC | 1 |
| masr ang | PERSON | 1 |
| med doi | PERSON | 1 |
| mechanisms of dysfunction | ORG | 1 |
| mers cov a systematic review | ORG | 1 |
| mechanical stress | ORG | 1 |
| measles coxsackie virus b4 | TAXON | 1 |
| meaningful | PERSON | 1 |
| mdm2 | PERSON | 1 |
| mcginley l patients | ORG | 1 |
| maternal haplotypes | PERSON | 1 |
| masson s trichrome | PERSON | 1 |
| massey | GPE | 1 |
| masr mas | ORG | 1 |
| mas sars | PERSON | 1 |
| mammalian ulk1 complex | TAXON | 1 |
| mas multiple | ORG | 1 |
| mas losartan | PERSON | 1 |
| mas detection | PERSON | 1 |
| mas angiotensin | PERSON | 1 |
| mary f lyon | PERSON | 1 |
| martinez garcia | PERSON | 1 |
| maria luisa | PERSON | 1 |
| marfan syndrome | DISEASE | 1 |
| marcus cremonese medical illustration | ORG | 1 |
| marcia et al | PERSON | 1 |
| mao | PERSON | 1 |
| mammary tumors | ORG | 1 |
| mers cov sars cov 2 | ORG | 1 |
| lombardy s regional health service | ORG | 1 |
| mers cov 29 | ORG | 1 |
| lkb1 angiotensin ii | PERSON | 1 |
| losartan identification | ORG | 1 |
| losartan heart failure | CHEMICAL | 1 |
| lopinavir ritonavir | CHEMICAL | 1 |
| lopinavir | PERSON | 1 |
| loop | PERSON | 1 |
| lombardy characteristics | ORG | 1 |
| lodi | PERSON | 1 |
| locally advanced metastatic | ORG | 1 |
| locally | ORG | 1 |
| localized | PERSON | 1 |
| local ras | ORG | 1 |
| llorens cortes s | PERSON | 1 |
| liver and muscle stimulate p33 messenger ribonucleic acid | DISEASE | 1 |
| mek2 mitogen extracellular | PERSON | 1 |
| liver phosphorylase ii enzymatic inactivation | ORG | 1 |
| liu bi cheng | PERSON | 1 |
| liu | PERSON | 1 |
| liraglutide increases ace2 expression | ORG | 1 |
| liraglutide | CHEMICAL | 1 |
| lipoproteins | CHEMICAL | 1 |
| linear | ORG | 1 |
| ligand | GPE | 1 |
| lifespan autophagy | PERSON | 1 |
| li et al 2004 | PERSON | 1 |
| medline | PERSON | 1 |
| leukocyte | PERSON | 1 |
| losartan an arb | ORG | 1 |
| louise burrell | PERSON | 1 |
| louise m angus peter w title | PERSON | 1 |
| lowry | PERSON | 1 |
| mec | CHEMICAL | 1 |
| mdr | CHEMICAL | 1 |
| matα trp1 ura3 | PERSON | 1 |
| mas ang | PERSON | 1 |
| mas activation | ORG | 1 |
| map kinase activation | ORG | 1 |
| map kinase | PERSON | 1 |
| m6p | ORG | 1 |
| m32 | CHEMICAL | 1 |
| m14 | PERSON | 1 |
| lysophosphatidylinositol | CHEMICAL | 1 |
| lys 548 | PERSON | 1 |
| lymphocyte ratio predicts severe illness patients | ORG | 1 |
| luteolin curcumin | PERSON | 1 |
| lung injury | DISEASE | 1 |
| lung fibrosis | ORG | 1 |
| lung cancer international | ORG | 1 |
| lung cancer int | PERSON | 1 |
| luminespib with potent antitumor | ORG | 1 |
| luis miguel | PERSON | 1 |
| lucille | GPE | 1 |
| lubel john s | PERSON | 1 |
| lu chen chen hu ze | PERSON | 1 |
| lu chen chen wang gui hua lu | PERSON | 1 |
| lphenylalanylglycylglycine | GPE | 1 |
| medicare | ORG | 1 |
| ncbi records https www ncbi nlm | ORG | 1 |
| mehra | PERSON | 1 |
| nadph oxidases | ORG | 1 |
| nf | GPE | 1 |
| nct04375124 | CHEMICAL | 1 |
| nct04355936 | CHEMICAL | 1 |
| nct04318418 198 199 200 potential | CHEMICAL | 1 |
| nct04318418 | ORG | 1 |
| nct04312009 nct04311177 | PERSON | 1 |
| nct00978523 | ORG | 1 |
| nct | CHEMICAL | 1 |
| ncbi s geo | PERSON | 1 |
| nbb b b | CHEMICAL | 1 |
| nbb | ORG | 1 |
| natr | ORG | 1 |
| nadh | CHEMICAL | 1 |
| mehra et al | PERSON | 1 |
| n terminus gace | ORG | 1 |
| n terminus amino acid | CHEMICAL | 1 |
| n terminal transmembrane domains and or c terminal mutations | CHEMICAL | 1 |
| n terminal lid | CHEMICAL | 1 |
| n terminal catalytic | CHEMICAL | 1 |
| n terminal active site of human angiotensinconverting enzyme the n terminal active | CHEMICAL | 1 |
| n ras k | CHEMICAL | 1 |
| n neprilysin | CHEMICAL | 1 |
| n acetylglucosamine | CHEMICAL | 1 |
| n acetyl seryl | CHEMICAL | 1 |
| n ras | ORG | 1 |
| n ang iii | PERSON | 1 |
| ng108 | TAXON | 1 |
| nhmrc | ORG | 1 |
| nhs foundation trust | ORG | 1 |
| nibt | ORG | 1 |
| leprdb db mice protection of mitochondria | ORG | 1 |
| nefh prrko | LOC | 1 |
| neal | PERSON | 1 |
| native | GPE | 1 |
| national kidney foundation hypertension | ORG | 1 |
| national health and nutrition examination survey | ORG | 1 |
| narasimhan m et al | PERSON | 1 |
| naoerkang nek | PERSON | 1 |
| naoerkang | GPE | 1 |
| namsolleck | CHEMICAL | 1 |
| nampt angii | PERSON | 1 |
| nakagawa | GPE | 1 |
| nagase | PERSON | 1 |
| nabah et al 2004 | PERSON | 1 |
| nacl decreases or blood pressure | CHEMICAL | 1 |
| na h | PERSON | 1 |
| na 1 | ORG | 1 |
| nyc | ORG | 1 |
| nsc23766 | CHEMICAL | 1 |
| nrti lamivudine | CHEMICAL | 1 |
| notch | ORG | 1 |
| nmr | ORG | 1 |
| nln | ORG | 1 |
| nl63 respiratory coronavirus receptor binding domain | TAXON | 1 |
| nk | GPE | 1 |
| n 3 2 furyl acryloyl lphenylalanylglycylglycine | CHEMICAL | 1 |
| n 2 aminoethyl 1 aziridine ethanamine | CHEMICAL | 1 |
| n 2 | ORG | 1 |
| mitochondrial | LOC | 1 |
| minireview | GPE | 1 |
| mineralocorticoid | ORG | 1 |
| min zhang yan | PERSON | 1 |
| mima | GPE | 1 |
| milan | GPE | 1 |
| mihara | GPE | 1 |
| migratory | GPE | 1 |
| midkine | CHEMICAL | 1 |
| middle east respiratory syndrome chloroquine | LOC | 1 |
| microtubules | TAXON | 1 |
| microtubule associated protein 2 | PERSON | 1 |
| michigan | GPE | 1 |
| mice transgenic | TAXON | 1 |
| mice angiotensin ii | LOC | 1 |
| mgcl 2 1 mm cacl 2 1 triton x 100 10 mg ml aprotinin | CHEMICAL | 1 |
| metabolic dynamics | ORG | 1 |
| met leu phe fmlp | PERSON | 1 |
| met | CHEMICAL | 1 |
| merscher gomez | PERSON | 1 |
| merscher | PERSON | 1 |
| meng et al | PERSON | 1 |
| mendelsohn et | PERSON | 1 |
| membrane | ORG | 1 |
| melanie webster | PERSON | 1 |
| mehra et al 10 | PERSON | 1 |
| misra 2020 kai | PERSON | 1 |
| mohammed el tabaa | PERSON | 1 |
| mytilus edulis | TAXON | 1 |
| mohammed el tabaa maram | PERSON | 1 |
| myocardial infarction | DISEASE | 1 |
| myocardial remodeling | ORG | 1 |
| myocardial ischemia reperfusion injury ampk regulation | ORG | 1 |
| myocardial ischemia reperfusion injury | DISEASE | 1 |
| myocardial | ORG | 1 |
| mycoplasma | ORG | 1 |
| myd88 | PERSON | 1 |
| mutant n ras are rapidly reduced | ORG | 1 |
| muscle molecular basis | ORG | 1 |
| muscle cell stiffness syndrome | DISEASE | 1 |
| murad | GPE | 1 |
| mundel and | PERSON | 1 |
| mundel | PERSON | 1 |
| mumps influenza measles | PERSON | 1 |
| multilocus | PERSON | 1 |
| mullins | PERSON | 1 |
| muhammad abdul zaidi syed tabish razi merchant hamid | PERSON | 1 |
| mucociliary | PERSON | 1 |
| ms melinda judson | PERSON | 1 |
| ms cassandra | PERSON | 1 |
| mouse podocyte | TAXON | 1 |
| mortality | DISEASE | 1 |
| montelukast | CHEMICAL | 1 |
| molar | GPE | 1 |
| mol med doi | PERSON | 1 |
| leu phe | PERSON | 1 |
| ichihara | GPE | 1 |
| lennon | PERSON | 1 |
| iv ang iv | PERSON | 1 |
| immunocytochemistry | ORG | 1 |
| immunity covid 19 | ORG | 1 |
| immune clearance of senescent cells | ORG | 1 |
| illumina | GPE | 1 |
| ige | ORG | 1 |
| identifier nct04312009 losartan | PERSON | 1 |
| identification of three | ORG | 1 |
| identification of renin | ORG | 1 |
| identi | GPE | 1 |
| ichihara et al 2006 | PERSON | 1 |
| nephron | ORG | 1 |
| iba 1 microglia | ORG | 1 |
| irap | PERSON | 1 |
| lemley 2015 | ORG | 1 |
| ipf block | DISEASE | 1 |
| ipf | ORG | 1 |
| ip3 diacylglycerol tyrosine | CHEMICAL | 1 |
| introduction | ORG | 1 |
| impress | ORG | 1 |
| il1 b ifn c | ORG | 1 |
| il1 b ifn | CHEMICAL | 1 |
| il 6 prevention | ORG | 1 |
| il 20 | ORG | 1 |
| il 17 | ORG | 1 |
| il 13 | ORG | 1 |
| ikb nf | ORG | 1 |
| implications | CHEMICAL | 1 |
| importantly ang 1 7 | PERSON | 1 |
| improves infarct perfusion in experimental heart failure antihypertensive | ORG | 1 |
| in vitro raf 1 activates | ORG | 1 |
| international clinical trials registry | ORG | 1 |
| interleukin 6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin ii type 1 receptor endothelium | ORG | 1 |
| interim | ORG | 1 |
| interestingly ace | ORG | 1 |
| interaction | ORG | 1 |
| intensive care units | ORG | 1 |
| intensive care medicine a | ORG | 1 |
| int | PERSON | 1 |
| insel 2020 | PERSON | 1 |
| inmaculada | GPE | 1 |
| injury | ORG | 1 |
| initiation | ORG | 1 |
| inhibitors | PERSON | 1 |
| inhibiting drp1 | PERSON | 1 |
| inhibiteur | CHEMICAL | 1 |
| inherited | DISEASE | 1 |
| influence of selected natural products | ORG | 1 |
| influence of sacubtril valsartan | ORG | 1 |
| infections | DISEASE | 1 |
| infarct | DISEASE | 1 |
| induction of arrhythmias | ORG | 1 |
| induction of apoptosis | ORG | 1 |
| individual genetic susceptibility receptivity role | ORG | 1 |
| inc decatur ga usa | PERSON | 1 |
| inagi 2017 targeting | ORG | 1 |
| iii n | ORG | 1 |
| ii studies | ORG | 1 |
| ii renin | CHEMICAL | 1 |
| hisint | ORG | 1 |
| hiroshi itoh | PERSON | 1 |
| hippuryl his leu 25 | PERSON | 1 |
| hippo yap signaling reduces mutant k ras expression | ORG | 1 |
| heterozygote | ORG | 1 |
| herrmann | PERSON | 1 |
| hereditary | PERSON | 1 |
| hepatitis b | DISEASE | 1 |
| heparan sulfate | CHEMICAL | 1 |
| heparan | PERSON | 1 |
| heme | PERSON | 1 |
| helmer 24 | PERSON | 1 |
| helmer | PERSON | 1 |
| heller | PERSON | 1 |
| helicobacter pylori | DISEASE | 1 |
| helicobacter | PERSON | 1 |
| heart failure | DISEASE | 1 |
| heart clinical | ORG | 1 |
| hashizume | GPE | 1 |
| hashimoto | DISEASE | 1 |
| hasan syed | PERSON | 1 |
| harvey p21ras | ORG | 1 |
| hart kristen c donoghue daniel j | ORG | 1 |
| hanff | PERSON | 1 |
| handbook of biologically active peptides | ORG | 1 |
| hancock | GPE | 1 |
| his leu | PERSON | 1 |
| histological | ORG | 1 |
| ifn gamma | CHEMICAL | 1 |
| hitachi tokyo | PERSON | 1 |
| idl | DISEASE | 1 |
| id | DISEASE | 1 |
| icr | ORG | 1 |
| ibv e1 | ORG | 1 |
| ibm usa measurement | ORG | 1 |
| hypoxia | GPE | 1 |
| hypertension angiotensin | DISEASE | 1 |
| hypertension local | ORG | 1 |
| hyperoxia | ORG | 1 |
| hydrolysis | PERSON | 1 |
| human podocyte | TAXON | 1 |
| human coronavirus | TAXON | 1 |
| human beings | TAXON | 1 |
| human protein | TAXON | 1 |
| human placental | ORG | 1 |
| human neutrophils | TAXON | 1 |
| human malignancies viral infections | DISEASE | 1 |
| hubei province 1 2 3 4 | TAXON | 1 |
| huang si | PERSON | 1 |
| hu et al 2018 | PERSON | 1 |
| houston | GPE | 1 |
| host viral | TAXON | 1 |
| hormone action comparative studies | ORG | 1 |
| hongrong | CHEMICAL | 1 |
| hong kong continuation | GPE | 1 |
| international union of basic and clinical | ORG | 1 |
| international union of pharmacology xlv classification | ORG | 1 |
| intracardiac | ORG | 1 |
| lri | ORG | 1 |
| ln reiser | PERSON | 1 |
| lmwh | ORG | 1 |
| lh rh ace | ORG | 1 |
| ldlr merscher gomez et | ORG | 1 |
| ldl | ORG | 1 |
| l name plus doca treated rats omapatrilat | ORG | 1 |
| l e1 11 ras 61l | CHEMICAL | 1 |
| l b inhibitor e | CHEMICAL | 1 |
| l 162 686 l 162 638 | CHEMICAL | 1 |
| kwon | PERSON | 1 |
| kuwait | GPE | 1 |
| kuba et al 20 | PERSON | 1 |
| kuba | PERSON | 1 |
| kristen c donoghue daniel j title derivatives of activated h ras lacking c terminal lipid modifications | CHEMICAL | 1 |
| krengel | PERSON | 1 |
| kow chia | PERSON | 1 |
| korea | GPE | 1 |
| kobayashi | PERSON | 1 |
| klinefelter syndrome | DISEASE | 1 |
| klinefelter | PERSON | 1 |
| kinase at1 | PERSON | 1 |
| kinase | PERSON | 1 |
| kim js | PERSON | 1 |
| kim | PERSON | 1 |
| kills pancreatic and blood | ORG | 1 |
| lnpep | ORG | 1 |
| ltp | ORG | 1 |
| khosravi far et al 1995 | PERSON | 1 |
| lamotte s silent | ORG | 1 |
| leloir | ORG | 1 |
| leica germany | GPE | 1 |
| lefèvre | CHEMICAL | 1 |
| left ventricular hypertrophy investigation | ORG | 1 |
| lefkowitz gilman | PERSON | 1 |
| lee 2011 | ORG | 1 |
| lee | PERSON | 1 |
| le | CHEMICAL | 1 |
| laybutt et al | PERSON | 1 |
| laybutt | DISEASE | 1 |
| laura castrejon | PERSON | 1 |
| larter | PERSON | 1 |
| larsen | PERSON | 1 |
| larner | ORG | 1 |
| lanthiopep b v | ORG | 1 |
| lanthiopep | ORG | 1 |
| langerhans angiotensin ii | PERSON | 1 |
| landa | GPE | 1 |
| lan et al | PERSON | 1 |
| lambert | GPE | 1 |
| laemmli | ORG | 1 |
| lactobacillus | GPE | 1 |
| lack of association | ORG | 1 |
| lack | PERSON | 1 |
| lacal | GPE | 1 |
| kidney disease | DISEASE | 1 |
| khan et al | PERSON | 1 |
| intracerebroventricular | ORG | 1 |
| jin | PERSON | 1 |
| jiangsu specially appointed professor program | ORG | 1 |
| jiangnan university | ORG | 1 |
| jian chen pei pei | PERSON | 1 |
| jian chen pei | PERSON | 1 |
| jehle 2014 | PERSON | 1 |
| jehle | CHEMICAL | 1 |
| jef de groote | PERSON | 1 |
| jan buss | PERSON | 1 |
| jamaica | GPE | 1 |
| jnk c | ORG | 1 |
| jnk nf | PERSON | 1 |
| jem | ORG | 1 |
| jama coronavirus | PERSON | 1 |
| jak | ORG | 1 |
| j e1 qi | CHEMICAL | 1 |
| izumi yasukatsu | PERSON | 1 |
| iwao hiroshi | PERSON | 1 |
| its normal cellular homologue | ORG | 1 |
| italy risk | GPE | 1 |
| isolation of an additional member of the fibroblast growth | ORG | 1 |
| isolation of | ORG | 1 |
| ischemia reperfusion | DISEASE | 1 |
| ire1 | ORG | 1 |
| invitrogen carlsbad ca usa agarose | ORG | 1 |
| introduction | ORG | 1 |
| jim et al | PERSON | 1 |
| jingwei bian | PERSON | 1 |
| kf other | PERSON | 1 |
| john lubel | PERSON | 1 |
| kf | CHEMICAL | 1 |
| kenyon | PERSON | 1 |
| kelder et al | PERSON | 1 |
| kb kir4 | PERSON | 1 |
| kawasaki like syndrome | DISEASE | 1 |
| kawasaki like disease | DISEASE | 1 |
| katherine j kawai tatsuo | PERSON | 1 |
| kai | PERSON | 1 |
| kagiyama | PERSON | 1 |
| kks | ORG | 1 |
| kit | PERSON | 1 |
| kf | PERSON | 1 |
| kegg_pathway | CHEMICAL | 1 |
| kc | GPE | 1 |
| k pathway | ORG | 1 |
| k ras differentially regulate membrane association of pi3k pdk 1 | ORG | 1 |
| k e1 | CHEMICAL | 1 |
| k d | CHEMICAL | 1 |
| k akt 74 | PERSON | 1 |
| k akt | PERSON | 1 |
| jun n terminal kinase | ORG | 1 |
| jun cascade | PERSON | 1 |
| jun amino terminal kinases isolation | ORG | 1 |
| jun 87 | ORG | 1 |
| johnson | PERSON | 1 |
| nefh prrko mice | ORG | 1 |
| prone | ORG | 1 |
| neratinib a | CHEMICAL | 1 |
| sars cov 2 infection involvement | ORG | 1 |
| sars cov regulated | ORG | 1 |
| sars cov rt | ORG | 1 |
| sars cov cd209l | ORG | 1 |
| sars cov axis | DISEASE | 1 |
| sars cov ace2 | ORG | 1 |
| sars cov 36 | ORG | 1 |
| sars cov 229e infected | DISEASE | 1 |
| sars cov 229e | ORG | 1 |
| sars cov 22 renin | ORG | 1 |
| sars cov 2 to ace 2 | ORG | 1 |
| sars cov 2 patients reviewer expertise renal | ORG | 1 |
| sars cov 2 infection studies | ORG | 1 |
| sars cov 2 and sars cov | ORG | 1 |
| sacubitril | PERSON | 1 |
| sars cov 2 structural | ORG | 1 |
| sars cov 2 sars cov 2 | ORG | 1 |
| sars cov 2 risk | ORG | 1 |
| sars cov 2 infection | ORG | 1 |
| sars cov 2 host | ORG | 1 |
| sars cov 2 covid 19 | ORG | 1 |
| sars cov 2 clinical | ORG | 1 |
| sars cov 2 cell entry depends | ORG | 1 |
| sars cov 2 ace2 protein function interaction | ORG | 1 |
| sars cov2provide | DISEASE | 1 |
| sara co 2 virus 246 | CHEMICAL | 1 |
| sara co 2 virus 109 ang | CHEMICAL | 1 |
| sars cov sars like bat cov | DISEASE | 1 |
| sars cov cellular | ORG | 1 |
| sars cov coronavirus | DISEASE | 1 |
| sars covs | ORG | 1 |
| syst eur and progress prevention | ORG | 1 |
| syfpeithi | ORG | 1 |
| summary | ORG | 1 |
| sting | PERSON | 1 |
| stat | ORG | 1 |
| srebp | ORG | 1 |
| sr | ORG | 1 |
| sp b | CHEMICAL | 1 |
| sp a | CHEMICAL | 1 |
| sod | ORG | 1 |
| slc6a19 b | CHEMICAL | 1 |
| slc6a19 | CHEMICAL | 1 |
| sirs | DISEASE | 1 |
| shp 1 src | ORG | 1 |
| sfo pvn arc | LOC | 1 |
| sfas | CHEMICAL | 1 |
| scr | ORG | 1 |
| sbp | PERSON | 1 |
| sarscov | TAXON | 1 |
| sars virus | TAXON | 1 |
| sars hitchhiked | DISEASE | 1 |
| sars coronavirus a pneumonia | DISEASE | 1 |
| sars cov 2 | ORG | 1 |
| sars trilogy | ORG | 1 |
| sars mers | DISEASE | 1 |
| sara co 2 | ORG | 1 |
| sar cov 2 | ORG | 1 |
| sace | ORG | 1 |
| resveratrol | PERSON | 1 |
| respiratory syndrome coronavirus 2 infec renin | DISEASE | 1 |
| researches | PERSON | 1 |
| reninangiotensin aldosterone | CHEMICAL | 1 |
| renin angiotensin | PERSON | 1 |
| renin ec | PERSON | 1 |
| renin angiotensin system | PERSON | 1 |
| renal hypertrophy | DISEASE | 1 |
| renal and vascular hypertension | DISEASE | 1 |
| renal injury | DISEASE | 1 |
| renal fibrosis mechanisms | ORG | 1 |
| renal atp6ap2 | ORG | 1 |
| renal ace2 | ORG | 1 |
| ren et | PERSON | 1 |
| ren 1 | PERSON | 1 |
| release | ORG | 1 |
| related multi | ORG | 1 |
| reivinen et al | PERSON | 1 |
| reiser | PERSON | 1 |
| reid et | PERSON | 1 |
| ref sars cov | PERSON | 1 |
| reduced | ORG | 1 |
| redmond washington usa | GPE | 1 |
| receptor complexes | PERSON | 1 |
| recently gatineau et al | PERSON | 1 |
| reactive | ORG | 1 |
| response | GPE | 1 |
| reviewer expertise | ORG | 1 |
| saax cmscksvls | PERSON | 1 |
| right ventricular dysfunction | DISEASE | 1 |
| saa tumor necrosis | CHEMICAL | 1 |
| s6k1 | LOC | 1 |
| s4 subgroup | ORG | 1 |
| s met | CHEMICAL | 1 |
| résumé la découverte | LOC | 1 |
| rénine | DISEASE | 1 |
| ryan paul macdaragh caplice noel | PERSON | 1 |
| ruxolitinib jakafi w | PERSON | 1 |
| ruxolitinib | CHEMICAL | 1 |
| ruotsalainen | PERSON | 1 |
| rubella | TAXON | 1 |
| ruan xiong | PERSON | 1 |
| rs495828 | CHEMICAL | 1 |
| rotterdam study | PERSON | 1 |
| roseburia | GPE | 1 |
| ronco | GPE | 1 |
| romero et al | PERSON | 1 |
| role of podocyte injury | ORG | 1 |
| role of nadph | ORG | 1 |
| rodriguez | PERSON | 1 |
| rodent | TAXON | 1 |
| robin van den eynde | PERSON | 1 |
| robin | DISEASE | 1 |
| robert tigerstedt | PERSON | 1 |
| robert | PERSON | 1 |
| saab | ORG | 1 |
| sacubtril valsartan | CHEMICAL | 1 |
| neratinib activity | PERSON | 1 |
| speth robert c title | PERSON | 1 |
| stimulation of ang ii | ORG | 1 |
| stevens | PERSON | 1 |
| steroid | ORG | 1 |
| steckelings | CHEMICAL | 1 |
| statin therapy | PERSON | 1 |
| statin | CHEMICAL | 1 |
| sriramula et al | PERSON | 1 |
| sriramula | CHEMICAL | 1 |
| sriram | PERSON | 1 |
| src egfr | PERSON | 1 |
| src | PERSON | 1 |
| spironolactone | CHEMICAL | 1 |
| spectrophotometric | ORG | 1 |
| safranin | CHEMICAL | 1 |
| specific | GPE | 1 |
| speci | ORG | 1 |
| spearman | PERSON | 1 |
| spain | GPE | 1 |
| souza | GPE | 1 |
| sorensson | ORG | 1 |
| sonneveld | GPE | 1 |
| sommerstein | PERSON | 1 |
| sommer | PERSON | 1 |
| soetikno et al 2013 | PERSON | 1 |
| sodium | CHEMICAL | 1 |
| sodhi | PERSON | 1 |
| stivarga | CHEMICAL | 1 |
| strategies and challenges | ORG | 1 |
| structural substrate conditions required for neutral endopeptidase mediated natriuretic peptide degradation | ORG | 1 |
| studies | ORG | 1 |
| habib | PERSON | 1 |
| tb | ORG | 1 |
| taz yap | ORG | 1 |
| tao | CHEMICAL | 1 |
| tace | ORG | 1 |
| t790m mutation | ORG | 1 |
| t2dm lennon et al 2009 sieber | PERSON | 1 |
| t2d | DISEASE | 1 |
| t1dm | DISEASE | 1 |
| t transversion | DISEASE | 1 |
| t cell dysfunction | DISEASE | 1 |
| szeto | PERSON | 1 |
| szabo et al 2006 | PERSON | 1 |
| systolic hypertension | ORG | 1 |
| systematic | LOC | 1 |
| syndrome of inappropriate anti diuretic hormone secretion | DISEASE | 1 |
| sutherland | PERSON | 1 |
| surg doi | PERSON | 1 |
| suppresses dengue virus replication | ORG | 1 |
| superoxide | CHEMICAL | 1 |
| subpopulations | ORG | 1 |
| subjects | CHEMICAL | 1 |
| subfornical | ORG | 1 |
| subfamilies | CHEMICAL | 1 |
| sturgill | PERSON | 1 |
| sobeai | CHEMICAL | 1 |
| slac laboratory animal shanghai | ORG | 1 |
| sinnayah | GPE | 1 |
| serpentine | CHEMICAL | 1 |
| sergio boulton michael e raizada mohan | PERSON | 1 |
| seoul | GPE | 1 |
| senostatics a | ORG | 1 |
| senolytics | ORG | 1 |
| senescent vascular smooth muscle cells drive inflammation through | ORG | 1 |
| senescent | LOC | 1 |
| senescence and mitochondrial fission | ORG | 1 |
| selectin | PERSON | 1 |
| seattle | GPE | 1 |
| seaplaque | PERSON | 1 |
| sexy | ORG | 1 |
| scott robertson ryan dellinger | PERSON | 1 |
| schneider | PERSON | 1 |
| schiffer | PERSON | 1 |
| saudi arabia identification | ORG | 1 |
| sarcoma | DISEASE | 1 |
| sapouckey | PERSON | 1 |
| santos et al | PERSON | 1 |
| santos | GPE | 1 |
| santa cruz biotechnology usa | GPE | 1 |
| sanchez nino et al | PERSON | 1 |
| salmonella cadba | PERSON | 1 |
| salmonella | PERSON | 1 |
| sakai | CHEMICAL | 1 |
| saijonmaa o title renin angiotensin | CHEMICAL | 1 |
| serino | CHEMICAL | 1 |
| severity of severe acute respiratory syndrome | ORG | 1 |
| singapore | GPE | 1 |
| sex omics era structure | ORG | 1 |
| sin b doi | TAXON | 1 |
| sin b | DISEASE | 1 |
| sin | TAXON | 1 |
| simões | GPE | 1 |
| simons et al 2001 | PERSON | 1 |
| sim1 | PERSON | 1 |
| silent | ORG | 1 |
| significance | ORG | 1 |
| sigma usa | PERSON | 1 |
| sigma aldrich usa | PERSON | 1 |
| sieber et al 2010 | ORG | 1 |
| sieber | PERSON | 1 |
| siadh | ORG | 1 |
| shock | DISEASE | 1 |
| shijia wang | PERSON | 1 |
| shih | PERSON | 1 |
| shi | PERSON | 1 |
| shanghai johnson johnson medical devices company | ORG | 1 |
| sgk1 selective | ORG | 1 |
| sgk1 minimal | LOC | 1 |
| sgk1 | ORG | 1 |
| seyhan turk | PERSON | 1 |
| sexual dimorphism | DISEASE | 1 |
| sexual | PERSON | 1 |
| sex related | CHEMICAL | 1 |
| rationale | ORG | 1 |
| ratio kidney disease | DISEASE | 1 |
| ratio kidney | PERSON | 1 |
| ostensibly | ORG | 1 |
| pcr sequencing | ORG | 1 |
| par | ORG | 1 |
| pai | ORG | 1 |
| paf | ORG | 1 |
| p markey charitable trust | ORG | 1 |
| oxytocin gastrin | PERSON | 1 |
| oxytocin | CHEMICAL | 1 |
| oxygen | CHEMICAL | 1 |
| overactive | DISEASE | 1 |
| overactivation of bone marrow derived immune | DISEASE | 1 |
| ottawa scale nos | ORG | 1 |
| osteomeasure | ORG | 1 |
| osimertinib | GPE | 1 |
| rathinasabapathy et al 2018 | PERSON | 1 |
| organic | ORG | 1 |
| orchidectomy | ORG | 1 |
| oral | ORG | 1 |
| oosterlinck wouter | ORG | 1 |
| onset | GPE | 1 |
| ondetti | ORG | 1 |
| oncogenic kras addiction in pancreatic cancer downstream of mutant | ORG | 1 |
| oncogene science | PERSON | 1 |
| oncogene | ORG | 1 |
| olympus japan | LOC | 1 |
| olmesartan | CHEMICAL | 1 |
| oleic acid | CHEMICAL | 1 |
| pct | ORG | 1 |
| pd123177 pd123319 | DISEASE | 1 |
| pdgf | ORG | 1 |
| pdgf binding | PERSON | 1 |
| pancreatic cancer | DISEASE | 1 |
| pan et al 2008 | PERSON | 1 |
| palmitic acid | CHEMICAL | 1 |
| palmitic | CHEMICAL | 1 |
| page | PERSON | 1 |
| pvntargeted | ORG | 1 |
| ptp | ORG | 1 |
| prrko | CHEMICAL | 1 |
| prrar | CHEMICAL | 1 |
| prisma | PERSON | 1 |
| prism graphpad software | ORG | 1 |
| prcp | ORG | 1 |
| pnecs hyperplasia | DISEASE | 1 |
| pnec | CHEMICAL | 1 |
| pn | GPE | 1 |
| pla 2 | ORG | 1 |
| pka pathway | ORG | 1 |
| pjs tumour | CHEMICAL | 1 |
| pip2 | CHEMICAL | 1 |
| pioneer | ORG | 1 |
| pgc 1α deficiency | DISEASE | 1 |
| pgc 1α | CHEMICAL | 1 |
| pgc 1alpha | CHEMICAL | 1 |
| pei cellulose | CHEMICAL | 1 |
| pei | ORG | 1 |
| oleic | ORG | 1 |
| okayama | GPE | 1 |
| odyssey infrared imaging system li cor usa | ORG | 1 |
| nijenhuis | PERSON | 1 |
| niewold 2015 | ORG | 1 |
| nidovirales | PERSON | 1 |
| nicotinamide adenine dinucleotide | CHEMICAL | 1 |
| nicotinamide | CHEMICAL | 1 |
| nicholas p henshaw | PERSON | 1 |
| nguyen et al 48 | PERSON | 1 |
| next | ORG | 1 |
| new mass | GPE | 1 |
| new approaches | GPE | 1 |
| new zealand | GPE | 1 |
| new york times coronavirus | ORG | 1 |
| new york | GPE | 1 |
| new orleans fox | GPE | 1 |
| new orleans | GPE | 1 |
| new jersey | GPE | 1 |
| neuronal | ORG | 1 |
| neuron | ORG | 1 |
| neurological dysfunction | DISEASE | 1 |
| neurological and neuropsychiatric complications | DISEASE | 1 |
| neurological | ORG | 1 |
| neuroendocrine | PERSON | 1 |
| neuroblastoma | DISEASE | 1 |
| netherlands | GPE | 1 |
| neratinib neratinib | PERSON | 1 |
| neratinib an | PERSON | 1 |
| nigerians jamaicans | PERSON | 1 |
| nitric | PERSON | 1 |
| odyssey application software | ORG | 1 |
| nitric oxide | CHEMICAL | 1 |
| occam | DISEASE | 1 |
| obukhov alexander g stevens bruce | PERSON | 1 |
| orx l 10 | ORG | 1 |
| orx l | PERSON | 1 |
| ontarget | ORG | 1 |
| oc43 1967 common cold 9 o ac sia | DISEASE | 1 |
| o ac sia | CHEMICAL | 1 |
| nyagan | CHEMICAL | 1 |
| nterminally | ORG | 1 |
| nterminal | GPE | 1 |
| nsp14 | ORG | 1 |
| novick 1993 | ORG | 1 |
| novel coronavirus pneumonia emergency response epidemiology team | ORG | 1 |
| novel | GPE | 1 |
| novartis | ORG | 1 |
| noticeably | ORG | 1 |
| notably | ORG | 1 |
| norway | GPE | 1 |
| north america | LOC | 1 |
| nonsteroid | ORG | 1 |
| nonetheless | ORG | 1 |
| nonclassic | PERSON | 1 |
| noncanonical functions of ulk | ORG | 1 |
| noble euan | PERSON | 1 |
| nlinked | ORG | 1 |
| pancreatic ductal adenocarcinoma | DISEASE | 1 |
| pancreatic ductal adenocarcinoma primary structure | ORG | 1 |
| pancreatic and blood cancer | DISEASE | 1 |
| rasassociated | ORG | 1 |
| ras dysregulation | DISEASE | 1 |
| ras dysfunction | DISEASE | 1 |
| ras abnormality | DISEASE | 1 |
| ras whereas ace | ORG | 1 |
| ras angiotensin iv | PERSON | 1 |
| ras ang iii | PERSON | 1 |
| ras ang ii | PERSON | 1 |
| rankl | ORG | 1 |
| rage | PERSON | 1 |
| raf 1 82 85 | ORG | 1 |
| raa | ORG | 1 |
| quigg 2015 | PERSON | 1 |
| qiu zhihua yan sen chen fen wang min yang | PERSON | 1 |
| qin | PERSON | 1 |
| qi | PERSON | 1 |
| qt prolongation | DISEASE | 1 |
| qrs | ORG | 1 |
| q37 | PERSON | 1 |
| q mismatch hypoxemia | DISEASE | 1 |
| pyrroloquinoline quinone | CHEMICAL | 1 |
| pyrroloquinoline | ORG | 1 |
| pyrococcus | GPE | 1 |
| pyr apelin 13 | PERSON | 1 |
| pyr apelin | CHEMICAL | 1 |
| pursuing | PERSON | 1 |
| ras inhibitor | ORG | 1 |
| rasrelated | ORG | 1 |
| pulmonary hypertension | DISEASE | 1 |
| results | ORG | 1 |
| rat model yap taz functions | ORG | 1 |
| rat hepatocytes | TAXON | 1 |
| rat coronavirus | TAXON | 1 |
| ras ci h ras | PERSON | 1 |
| ras independent mechanisms | ORG | 1 |
| ras guanine nucleotide releasing factor hsos1 binds | ORG | 1 |
| ras dependent | PERSON | 1 |
| ramipril global endpoint trial | ORG | 1 |
| raising nicotinamide adenine dinucleotide dependent | ORG | 1 |
| rac1 inhibitor nsc23766 | ORG | 1 |
| rac rho | PERSON | 1 |
| rac | PERSON | 1 |
| rabin rc obesity | PERSON | 1 |
| rxpa380 n | CHEMICAL | 1 |
| rta | DISEASE | 1 |
| rt pcr | ORG | 1 |
| ros nox | ORG | 1 |
| ros nephrin | ORG | 1 |
| ros 20 ros | ORG | 1 |
| romk renal outer medulla potassium | ORG | 1 |
| romk | ORG | 1 |
| rnaseq | CHEMICAL | 1 |
| rlr | ORG | 1 |
| rk | CHEMICAL | 1 |
| ria | ORG | 1 |
| pulmonary hypertension | DISEASE | 1 |
| puelles et al 2016 | PERSON | 1 |
| pandemic malaria | DISEASE | 1 |
| podocin | CHEMICAL | 1 |
| pluznick et al 24 | PERSON | 1 |
| platelet aggregation | DISEASE | 1 |
| plasmodium falciparum | DISEASE | 1 |
| piacenza | ORG | 1 |
| phosphotyrosine | CHEMICAL | 1 |
| phosphorylase | PERSON | 1 |
| phosphoinositide | CHEMICAL | 1 |
| phosphatidylinositol 3 4 5 trisphosphate | CHEMICAL | 1 |
| phosphatidyl inositol | CHEMICAL | 1 |
| phosphate | CHEMICAL | 1 |
| phillips m ian de oliveira | ORG | 1 |
| pheromone | CHEMICAL | 1 |
| pharmacol ther | PERSON | 1 |
| pharmacol rep | PERSON | 1 |
| peutz jeghers syndrome pjs | DISEASE | 1 |
| peter sommerfeld nigel | PERSON | 1 |
| peter angus | PERSON | 1 |
| per bergman | PERSON | 1 |
| peptidase | ORG | 1 |
| paul fisher | PERSON | 1 |
| patricia d avis | PERSON | 1 |
| paton | GPE | 1 |
| partially purified plasma membranes | ORG | 1 |
| park | GPE | 1 |
| paraprevotella | ORG | 1 |
| po river | LOC | 1 |
| podocytespecific | ORG | 1 |
| pubmed | ORG | 1 |
| positive | ORG | 1 |
| pubmed abstract publisher | ORG | 1 |
| pubmed | PERSON | 1 |
| pshai | PERSON | 1 |
| pseudomonas aeruginosa infection | DISEASE | 1 |
| pseudomonas aeruginosa | TAXON | 1 |
| pseudomonas | GPE | 1 |
| proximal | ORG | 1 |
| protezione | CHEMICAL | 1 |
| proteolytic | LOC | 1 |
| proteobacteria | PERSON | 1 |
| proteinuria | PERSON | 1 |
| proteins related | PERSON | 1 |
| proteinase k | PERSON | 1 |
| prostate | DISEASE | 1 |
| proline | CHEMICAL | 1 |
| progerin | CHEMICAL | 1 |
| proc natl | PERSON | 1 |
| proc | PERSON | 1 |
| pro phe his leu | CHEMICAL | 1 |
| pro phe arg | CHEMICAL | 1 |
| pro gly phe | CHEMICAL | 1 |
| preprint robertson 2020 | PERSON | 1 |
| preprint | CHEMICAL | 1 |
| prebotzinger | ORG | 1 |
| potassium maxi k channel | PERSON | 1 |
| hadjadj | PERSON | 1 |
| ace inhibitor enalapril | CHEMICAL | 1 |
| hxxe | ORG | 1 |
| amino acid | CHEMICAL | 1 |
| ang ii ang iv | PERSON | 1 |
| ang ii ang iii ang iv ang | PERSON | 1 |
| ang ii ang iii ang iv | PERSON | 1 |
| ang ii ang iii ang ii | PERSON | 1 |
| ang ii ace | PERSON | 1 |
| ang i ang | PERSON | 1 |
| ang 2 8 | PERSON | 1 |
| ang 1 7 fig 2 angiotensin | ORG | 1 |
| ang 1 7 33 | PERSON | 1 |
| ando et al 2014 | PERSON | 1 |
| an n | ORG | 1 |
| amino acids | CHEMICAL | 1 |
| amercian association of gynecologic | ORG | 1 |
| angiotensin neprilysin | CHEMICAL | 1 |
| alzheimer type cardiovascular aging central | DISEASE | 1 |
| alzheimer s disease stroke memory and learning alcoholism stress depression | DISEASE | 1 |
| alzheimer s disease stroke memory and learning alcoholism depression | DISEASE | 1 |
| alzheimer s disease ad | DISEASE | 1 |
| alzheimer s dementia | DISEASE | 1 |
| alzheimer s abeta 1 16 peptide | DISEASE | 1 |